<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurotox Res</journal-id><journal-id journal-id-type="iso-abbrev">Neurotox Res</journal-id><journal-title-group><journal-title>Neurotoxicity Research</journal-title></journal-title-group><issn pub-type="ppub">1029-8428</issn><issn pub-type="epub">1476-3524</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5766721</article-id><article-id pub-id-type="publisher-id">9795</article-id><article-id pub-id-type="doi">10.1007/s12640-017-9795-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Targeting Sentinel Proteins and Extrasynaptic Glutamate Receptors: a Therapeutic Strategy for Preventing the Effects Elicited by Perinatal Asphyxia?</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Herrera-Marschitz</surname><given-names>Mario</given-names></name><address><phone>(56)-2-9786788</phone><email>mh-marschitz@med.uchile.cl</email><email>mhmarschitz@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Perez-Lobos</surname><given-names>Ronald</given-names></name><address><email>Ronald.perezlobos@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lespay-Rebolledo</surname><given-names>Carolyne</given-names></name><address><email>carolynelespay@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tapia-Bustos</surname><given-names>Andrea</given-names></name><address><email>ac.tapiabustos@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Casanova-Ortiz</surname><given-names>Emmanuel</given-names></name><address><email>Emanuel.casanovao@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Morales</surname><given-names>Paola</given-names></name><address><email>pmorales@med.uchile.cl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Valdes</surname><given-names>Jose-Luis</given-names></name><address><email>jlvaldes@med.uchile.cl</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Bustamante</surname><given-names>Diego</given-names></name><address><email>dbustama@med.uchile.cl</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cassels</surname><given-names>Bruce K.</given-names></name><address><email>bcassels@uchile.cl</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Programme of Molecular &#x00026; Clinical Pharmacology, ICBM, Faculty of Medicine, </institution><institution>University of Chile, </institution></institution-wrap>Av. Independencia, PO Box 8389100, 1027 Santiago, Chile </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 804X</institution-id><institution-id institution-id-type="GRID">grid.412848.3</institution-id><institution>Escuela de Tecnologia Medica, Facultad de Medicina, </institution><institution>Universidad Andres Bello, </institution></institution-wrap>PO Box 8370146, Santiago, Chile </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Faculty of Sciences, </institution><institution>University of Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Department of Neuroscience, Faculty of Medicine, </institution><institution>University of Chile, </institution></institution-wrap>Santiago, Chile </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="ppub"><year>2018</year></pub-date><volume>33</volume><issue>2</issue><fpage>461</fpage><lpage>473</lpage><history><date date-type="received"><day>26</day><month>7</month><year>2017</year></date><date date-type="rev-recd"><day>4</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>7</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Perinatal asphyxia (PA) is a relevant cause of death at the time of labour, and when survival is stabilised, associated with short- and long-term developmental disabilities, requiring inordinate care by health systems and families. Its prevalence is high (1 to 10/1000 live births) worldwide. At present, there are few therapeutic options, apart from hypothermia, that regrettably provides only limited protection if applied shortly after the insult.</p><p id="Par2">PA implies a primary and a secondary insult. The primary insult relates to the lack of oxygen, and the secondary one to the oxidative stress triggered by re-oxygenation, formation of reactive oxygen (ROS) and reactive nitrogen (RNS) species, and overactivation of glutamate receptors and mitochondrial deficiencies. PA induces overactivation of a number of sentinel proteins, including hypoxia-induced factor-1&#x003b1; (HIF-1&#x003b1;) and the genome-protecting poly(ADP-ribose) polymerase-1 (PARP-1). Upon activation, PARP-1 consumes high amounts of ATP at a time when this metabolite is scarce, worsening in turn the energy crisis elicited by asphyxia. The energy crisis also impairs ATP-dependent transport, including glutamate re-uptake by astroglia. Nicotinamide, a PARP-1 inhibitor, protects against the metabolic cascade elicited by the primary stage, avoiding NAD<sup>+</sup> exhaustion and the energetic crisis. Upon re-oxygenation, however, oxidative stress leads to nuclear translocation of the NF-&#x003ba;B subunit p65, overexpression of the pro-inflammatory cytokines IL-1&#x003b2; and TNF-&#x003b1;, and glutamate-excitotoxicity, due to impairment of glial-glutamate transport, extracellular glutamate overflow, and overactivation of NMDA receptors, mainly of the extrasynaptic type. This leads to calcium influx, mitochondrial impairment, and inactivation of antioxidant enzymes, increasing further the activity of pro-oxidant enzymes, thereby making the surviving neonate vulnerable to recurrent metabolic insults whenever oxidative stress is involved. Here, we discuss evidence showing that (i) inhibition of PARP-1 overactivation by nicotinamide and (ii) inhibition of extrasynaptic NMDA receptor overactivation by memantine can prevent the short- and long-term consequences of PA. These hypotheses have been evaluated in a rat preclinical model of PA, aiming to identify the metabolic cascades responsible for the long-term consequences induced by the insult, also assessing postnatal vulnerability to recurrent oxidative insults. Thus, we present and discuss evidence demonstrating that PA induces long-term changes in metabolic pathways related to energy and oxidative stress, priming vulnerability of cells with both the neuronal and the glial phenotype. The effects induced by PA are region dependent, the substantia nigra being particularly prone to cell death. The issue of short- and long-term consequences of PA provides a framework for addressing a fundamental issue referred to plasticity of the CNS, since the perinatal insult triggers a domino-like sequence of events making the developing individual vulnerable to recurrent adverse conditions, decreasing his/her coping repertoire because of a relevant insult occurring at birth.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Neonatal hypoxia</kwd><kwd>Hypoxic ischaemic encephalopathy (HIE)</kwd><kwd>Leukomalacia</kwd><kwd>Basal ganglia</kwd><kwd>MAP-2</kwd><kwd>GFAP</kwd><kwd>TUNEL</kwd><kwd>nNOS</kwd><kwd>Delayed cell death</kwd><kwd>Organotypic cultures</kwd><kwd>Niacinamide</kwd><kwd>Memantine</kwd><kwd>Rat</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC, part of Springer Nature 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>The Problem</title><p id="Par60">Pregnancy culminates at the time when labour begins, implying a complex interchange of molecules generated by uterine and extrauterine tissue, leading to increased myometrial contractility, cervical dilatation, decidual/membrane activation, and rupture of chorioamniotic membranes (Romero et al. <xref ref-type="bibr" rid="CR132">2006</xref>). The switch from a quiescent to a contractile myometrium is accompanied by a shift from anti-inflammatory to pro-inflammatory signalling chemokines and cytokines, as well as contraction-associated proteins, warranting a successful delivery (Romero et al. <xref ref-type="bibr" rid="CR133">2014</xref>). Delivery, however, can be a risky episode, whenever the onset of pulmonary respiration is delayed or interrupted, leading to perinatal asphyxia (PA) if oxygenation is not promptly established or re-established.</p><p id="Par61">PA is a relevant cause of death at the time of labour, associated with long-term consequences when re-oxygenation is established (Odd et al. <xref ref-type="bibr" rid="CR111">2009</xref>). Despite important advances in perinatal care (Kurinczuk et al. <xref ref-type="bibr" rid="CR83">2010</xref>; Basovich <xref ref-type="bibr" rid="CR11">2010</xref>), PA remains a severe condition, with high prevalence (1 to 10/1000 live births) worldwide, also associated with long-lasting neuropsychiatric dysfunctions when children reach critical developmental stages (see Douglas-Escobar and Weiss <xref ref-type="bibr" rid="CR34">2015</xref>).</p><p id="Par62">PA implies a deregulation of gas exchange resulting in hypoxemia, hypercapnia, and metabolic acidosis of vital organs, including the brain (Low <xref ref-type="bibr" rid="CR89">2004</xref>). The interruption of oxygen supply causes energy failure, triggering a biochemical cascade leading to cell dysfunction and ultimately to cell death, particularly affecting neurocircuitries of the basal ganglia and hippocampus (Klawitter et al. <xref ref-type="bibr" rid="CR78">2007</xref>; Morales et al. <xref ref-type="bibr" rid="CR103">2008</xref>; Neira-Pe&#x000f1;a et al. <xref ref-type="bibr" rid="CR108">2015</xref>). The long-term effects observed after PA also imply metabolic and neuronal network alterations, impairing the ability of the CNS to cope with stressors occurring during life (see Marriott et al. <xref ref-type="bibr" rid="CR95">2017</xref>).</p><p id="Par63">Hypoxia leads to generation of reactive oxygen (ROS) and reactive nitrogen (RNS) species, inhibiting prolyl-hydroxylases that under normoxia metabolise the oxygen sensor <italic>hypoxia-inducible factor-1alpha</italic> (HIF-1&#x003b1;). This is then poly-ubiquinated by von Hippel-Lindau tumour-suppressing factor (pVHL) and eliminated by the proteasome (Wang et al. <xref ref-type="bibr" rid="CR161">1995</xref>). Following the interruption of oxygen viability, HIF-1&#x003b1; accumulates and translocates to the nucleus, stimulating the expression of multiple genes associated with cell metabolism and mitochondrial function, down-regulating the citric acid cycle and enhancing anaerobic glycolysis, thus allowing the cells to cope with the low oxygen tension (Ke and Costa <xref ref-type="bibr" rid="CR76">2006</xref>; Vangeison et al. <xref ref-type="bibr" rid="CR154">2008</xref>). HIF-1&#x003b1; translocation stimulates pro-apoptotic genes, including the Bcl-2 family members Nix, Noxa, Bnip3, and apoptosis-inducing factor (AIF) (Bruick <xref ref-type="bibr" rid="CR18">2000</xref>; Sowter et al. <xref ref-type="bibr" rid="CR143">2001</xref>) but also the expression of sentinel proteins, such as poly(ADP-ribose) polymerase-1 (PARP-1). PARP-1 signalling occurs via the attachment of ADP-ribose chains to nuclear proteins recognised by DNA-repairing enzymes, such as DNA ligase III. The generation of ADP-ribose monomers requires, however, NAD<sup>+</sup>, which is why PARP-1 overactivation further depletes NAD<sup>+</sup> stores, resulting in progressive ATP depletion (Berger <xref ref-type="bibr" rid="CR13">1985</xref>; Hong et al. <xref ref-type="bibr" rid="CR64">2004</xref>). Furthermore, there is tight crosstalk between PARP-1 and HIF-1&#x003b1; (Martin-Oliva et al. <xref ref-type="bibr" rid="CR96">2006</xref>). Under hypoxic conditions and/or oxidative stress, PARP-1 modulates HIF-1&#x003b1; activity (Martinez-Romero et al. <xref ref-type="bibr" rid="CR97">2009</xref>). In turn, HIF-1&#x003b1; requires PARP-1 activation for exerting its transcriptional activity (Pan et al. <xref ref-type="bibr" rid="CR114">2013</xref>), while PARP-1 activity protects the HIF-2&#x003b1; isoform against pVHL-mediated destabilization (Gonzalez-Flores et al. <xref ref-type="bibr" rid="CR49">2014</xref>).</p><p id="Par64">Hypoxia implies a generalised impairment of Na<sup>+</sup>/K<sup>+</sup>-ATPase-dependent transport, including neurotransmitter re-uptake. A particular case is that of glutamate, which is largely synthesised by the astroglia-neuronal glutamine shuttle. It is not yet clear how ATPase modulates glutamate transport. However, arachidonic acid inhibits several sodium-coupled amino acid transporters, including that of glutamate, by a mechanism requiring Na<sup>+</sup>/K<sup>+</sup>-ATPase (Danbolt <xref ref-type="bibr" rid="CR30">2001</xref>). Furthermore, there is evidence showing that extracellular glutamate levels are buffered by ATP-dependent transport, to be taken up by glial and neuronal cells for metabolic degradation or re-cycling (Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR58">1996</xref>). ATP deficit decreases glutamate uptake, resulting in increased extracellular glutamate levels. Free radicals can also affect the members of the Na<sup>+</sup>/Cl<sup>&#x02212;</sup>-dependent transporter family, although the role of oxidative modulation of glutamate uptake under normal conditions is not yet known, and even less under hypoxia (Danbolt <xref ref-type="bibr" rid="CR30">2001</xref>). It has been shown, however, that glutamate transporters possess a sulfhydryl-based regulatory mechanism, which makes glutamate transporters sensitive to redox agents, resulting in increased or decreased transport (Trotti et al. <xref ref-type="bibr" rid="CR153">1997</xref>). It is hypothesised here that under sustained hypoxia the half-life of extracellular glutamate is prolonged. This might provide an extreme homeostatic response for widespread neuronal depolarization removing the organism from a catastrophic condition by extracellular glutamate binding to any available glutamate receptor, mainly of the extrasynaptic subtype. The NMDARs are heterotetramers composed by two NR1 (obligatory) and two NR2/3 subunits (Jacobucci and Popescu <xref ref-type="bibr" rid="CR70">2017</xref>), whose gating and ligand-binding properties depend on the NR2A/C subunit (Glasow et al. <xref ref-type="bibr" rid="CR47">2015</xref>). The NR2B-containing NMDARs are extrasynaptic in a significant proportion (Papouin et al. <xref ref-type="bibr" rid="CR115">2012</xref>). At birth, extrasynaptic NR2B-containing receptors prevail over the NR2A-containing NMDAR subtype. The NR2A-containing subtype is the predominant intrasynaptic mature NMDAR, associated with long-term plasticity (see Petralia <xref ref-type="bibr" rid="CR119">2012</xref>; Vizi et al. <xref ref-type="bibr" rid="CR159">2013</xref>). The NR2B subtype is associated with excitotoxic cascades and cell death, via Ca<sup>2+</sup> cellular entry and massive mitochondrial Ca<sup>2+</sup> loading (Loftis and Janosky <xref ref-type="bibr" rid="CR87">2003</xref>; Stanika et al. <xref ref-type="bibr" rid="CR144">2009</xref>). Thus, sustained hypoxia necessarily implies excitotoxicity, worsening in turn the metabolic crisis and death if respiration is not promptly established.</p><p id="Par65">Overstimulation of extrasynaptic NMDA receptors increases nitric oxide (NO) production, and further oxidative stress by formation of peroxynitrite upon its reaction with superoxide anions. NO can directly decrease mitochondrial membrane potentials, liberating pro-apoptotic proteins (Moncada and Bola&#x000f1;os <xref ref-type="bibr" rid="CR101">2006</xref>), including AIF, NADPH oxidase, and neuronal nitric oxide synthase (nNOS) (Hwang et al. <xref ref-type="bibr" rid="CR65">2002</xref>), provoking DNA fragmentation and mitochondrial fission, maintaining a condition of high ADP/ATP ratio and energy inefficiency (P&#x000e9;rez-Pinzon et al. <xref ref-type="bibr" rid="CR117">1999</xref>). Mitochondrial structure, function, and energy metabolism change over time, implicating that the physiology of mitochondria also evolves along the life span of an individual (Mattson <xref ref-type="bibr" rid="CR99">2007</xref>).</p><p id="Par66">Upon delivery and during neonatal and early developmental stages, oxidative stress is a permanent risk for the developing individual, enhanced by a sudden increase or decrease of metabolism associated with development itself or environment-dependent conditions, including malnutrition, fatigue, fever, infections, trauma, and/or inflammation-inducing injuries (Deng <xref ref-type="bibr" rid="CR33">2010</xref>). Oxidative stress produces an imbalance that favours the production of ROS over antioxidant defences (Orrenius et al. <xref ref-type="bibr" rid="CR113">2011</xref>), with hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) playing a pivotal role (Sies <xref ref-type="bibr" rid="CR141">2017</xref>). At low concentrations (1&#x02013;10&#x000a0;nM), H<sub>2</sub>O<sub>2</sub> leads to adaptative stress responses, while above 1&#x000a0;&#x003bc;M H<sub>2</sub>O<sub>2</sub> induces inflammation, growth arrest, and cell death (Deng <xref ref-type="bibr" rid="CR33">2010</xref>; Aschbacher et al. <xref ref-type="bibr" rid="CR9">2013</xref>).</p></sec><sec id="Sec2"><title>An Experimental Model of Global PA in Rats</title><p id="Par67">In our laboratory, we established an experimental model of global PA in rats, originally proposed by Borje Bjelke, Kurt Andersson, and collaborators at the Karolinska Institutet, Stockholm, Sweden, in the 1990s (Bjelke et al. <xref ref-type="bibr" rid="CR15">1991</xref>; Andersson et al. <xref ref-type="bibr" rid="CR7">1992</xref>; Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR56">1993</xref>). In this model, hypoxia occurs at the time when the rats are ready for or have begun delivery. The model has been pivotal for the study of relevant targets responsible for metabolic cascades leading to long-term effects (see Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR62">2011</xref>, <xref ref-type="bibr" rid="CR63">2014</xref>; recently reviewed by Barkhuizen et al. <xref ref-type="bibr" rid="CR10">2017</xref>).</p><p id="Par68">The model starts by a programmed mating. At the time of pro-oestrus, a female Wistar rat is exposed to a male for one night, looking the next day for a vaginal clot to exactly predict the time of delivery (22&#x000a0;days). When on term, a first spontaneous delivery is observed before the dam is neck-dislocated and subjected to hysterectomy to remove the foetus-containing uterine horns, which are immersed in a water bath at 37&#x000a0;&#x000b0;C for 21&#x000a0;min in order to induce severe asphyxia. The foetuses are manually delivered and stimulated to start breathing, and after a nursering period, the pups are given to surrogate dams pending further experiments. Sibling, spontaneous, or caesarean-delivered pups are used as controls (see Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR62">2011</xref>). The model allows monitoring early or delayed long-lasting molecular, metabolic, and physiological effects, or the pups can also be used to prepare organotypic cultures (Morales et al. <xref ref-type="bibr" rid="CR102">2003</xref>; Klawitter et al. <xref ref-type="bibr" rid="CR78">2007</xref>).</p><p id="Par69">PA is a menace to the full organism, affecting systemic and brain tissue. The availability of ATP is rapidly decreased in the kidneys, already after 5&#x000a0;min of PA, whereas brain ATP is decreased to less than 50% after 15&#x000a0;min of asphyxia if performed at 37&#x000a0;&#x000b0;C (Engidawork et al. <xref ref-type="bibr" rid="CR37">1997</xref>). Heart metabolism is sustained until the time when the lack of oxygenation is incompatible with life, largely supported by the &#x0201c;phosphocreatine shuttle&#x0201d; (Friedman and Roberts <xref ref-type="bibr" rid="CR42">1994</xref>), which is not useful for the neonatal brain (Lubec et al. <xref ref-type="bibr" rid="CR92">2000</xref>), although there is some clinical evidence showing that a creatine-supplemented diet protects the newborn from birth hypoxia (Ireland et al. <xref ref-type="bibr" rid="CR67">2008</xref>, <xref ref-type="bibr" rid="CR68">2011</xref>; Tachikawa et al. <xref ref-type="bibr" rid="CR146">2007</xref>), but further research is certainly required to evaluate the phosphocreatine shuttle in the developing brain.</p><p id="Par70">PA implies a primary and a secondary insult. The primary insult relates to the lack of oxygen, and the secondary one to the oxidative stress triggered by re-oxygenation, resulting in the formation of ROS and RNS, and overactivation of glutamate receptors and mitochondrial deficiencies, as recently discussed (Hagberg et al. <xref ref-type="bibr" rid="CR52">2016</xref>).</p></sec><sec id="Sec3"><title>The Hypoxic Insult</title><p id="Par71">The brain is vulnerable to a decrease of blood oxygen saturation, due to its high dependence on aerobic metabolism. Whenever hypoxia is sustained, there is a switch to glycolysis, a poor metabolic alternative because of the low glucose stores in newborn brain tissue and deficient ATP output by the glycolysis pathway, resulting in lactate accumulation and acidosis (Engidawork et al. <xref ref-type="bibr" rid="CR37">1997</xref>). The cerebral energy metabolism of newborn rodents and humans can utilise ketone bodies &#x003b2;-hydroxybutyrate and acetoacetate rather than glucose to satisfy cerebral energy requirements (see Nehlig and Pereira de Vasconcelos, <xref ref-type="bibr" rid="CR109">1993</xref>). In neonates, these ketone bodies are essential energy sources, produced by liver mitochondria and diffusing to other organs including the brain. Ketone uptake into the brain of the newborn is four to five times faster than that in older babies or infants (Cunnane and Crawford <xref ref-type="bibr" rid="CR29">2014</xref>). In adults, ketones can provide the energy requirements following prolonged fasting or starvation (Wang et al. <xref ref-type="bibr" rid="CR162">2014</xref>), and are also the main source of carbon to make cholesterol and long-chain fatty acids, important structural lipids for the developing brain (Cunnane et al. <xref ref-type="bibr" rid="CR28">1999</xref>). It is not yet known, however, if ketone bodies can compensate for the energy crisis elicited by hypoxia during the perinatal period.</p></sec><sec id="Sec4"><title>The Re-oxygenation Insult</title><p id="Par72">Re-oxygenation is a requirement for survival, leading necessarily to oxidative stress and free radical formation, excitotoxicity, intracellular calcium accumulation, mitochondrial dysfunction, and inactivation of buffering enzymes, resulting in a metabolic deficient condition, increasing CNS vulnerability to recurrent metabolic insults.</p><p id="Par73">Oxidative stress and free radical formation lead to inhibition of Na<sup>+</sup>-dependent glutamate uptake by astroglial cells, the main mechanism regulating extracellular glutamate levels (Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR58">1996</xref>; see Anderson and Swanson <xref ref-type="bibr" rid="CR6">2000</xref>) implicated in short- and long-term excitoxicity, as discussed by Herrera-Marschitz and Schmidt (<xref ref-type="bibr" rid="CR59">2000</xref>). The impairment of glial-glutamate transport leads to extracellular glutamate overflow. If not taken up, glutamate binds to extrasynaptic NMDARs, expressing at neonatal stage Ca<sup>2+</sup>-permeable NR2B and Mg<sup>2+</sup>-insensitive NR3A NMDAR subunits (Massey et al. <xref ref-type="bibr" rid="CR98">2004</xref>; see Groc et al. <xref ref-type="bibr" rid="CR50">2009</xref>; Hardingham and Bading <xref ref-type="bibr" rid="CR54">2010</xref>; Jantzie et al. <xref ref-type="bibr" rid="CR72">2015</xref>; also, Papouin et al. <xref ref-type="bibr" rid="CR115">2012</xref>). Overstimulation of extrasynaptic NMDAR increases Ca<sup>2+</sup> influx, triggering mitochondrial dysfunction and ROS and RNS formation (Starkov et al. <xref ref-type="bibr" rid="CR145">2004</xref>; Stanika et al. <xref ref-type="bibr" rid="CR144">2009</xref>), modifying lipids and macromolecules, such as proteins and nucleic acids (see Quincozes-Santos et al. <xref ref-type="bibr" rid="CR127">2014</xref>). There is evidence that NMDA receptor blockage improves mitochondrial respiration, preventing mitochondrial permeabilization during the reperfusion phase following hypoxic-ischaemic injury (Block and Schwarz <xref ref-type="bibr" rid="CR16">1996</xref>; Chen et al. <xref ref-type="bibr" rid="CR24">1998</xref>; Puka-Sundvall et al. <xref ref-type="bibr" rid="CR126">2000</xref>).</p><p id="Par74">ROS and RNS levels can overwhelm the capacity of cellular defence systems. ROS introduce post-translational oxidative carbonyl modifications on macromolecules (Lourenco dos Santos et al. <xref ref-type="bibr" rid="CR88">2015</xref>), while S-nitrosylation modifies reactive cysteine thiol on target proteins, leading to both protein misfolding and fission/fusion-dependent mitochondrial dysfunction and fragmentation (Nakamura and Lipton <xref ref-type="bibr" rid="CR105">2011</xref>). PARP-1 is further activated (Duan et al. <xref ref-type="bibr" rid="CR35">2007</xref>; Abramov and Duchen <xref ref-type="bibr" rid="CR1">2008</xref>), and AIF is translocated, triggering caspase-independent apoptosis (see Krantic et al. <xref ref-type="bibr" rid="CR81">2007</xref>). ROS alter I&#x003ba;B degradation, resulting in NF-&#x003ba;B activation, and nuclear translocation of the p65 subunit, which is increased in a PARP-1-dependent manner by PA (Neira-Pe&#x000f1;a et al. <xref ref-type="bibr" rid="CR108">2015</xref>). The global perinatal insults trigger inflammatory signalling in peripheral and brain tissues, implicating also vascular integrity. Cyclooxygenase-2 (COX-2), a marker of inflammation, is transiently elevated in rat brain exposed to PA, together with up- and subsequent down-regulation of antioxidant enzymes (Toti et al. <xref ref-type="bibr" rid="CR151">2001</xref>; Bonestroo et al. <xref ref-type="bibr" rid="CR17">2013</xref>). This suggests delayed vulnerability that could contribute to developmental abnormalities responsible for the behavioural alterations observed after PA (Piscopo et al. <xref ref-type="bibr" rid="CR122">2008</xref>), also in the ischaemic neonatal human brain (Toti et al. <xref ref-type="bibr" rid="CR151">2001</xref>). At neonatal stages, the effect of increased ROS and RNS is aggravated by immature defence mechanisms, including low expression/activity of the superoxide dismutase (SOD) family, glutathione peroxidase (GPx) (Samarasinghe et al. <xref ref-type="bibr" rid="CR137">2000</xref>), catalase (Lafemina et al. <xref ref-type="bibr" rid="CR84">2006</xref>), and peroxyredoxin-3 (Prx-3) (Chang et al. <xref ref-type="bibr" rid="CR22">2004</xref>). Prx-3 is exclusively located in mitochondria, co-localising with SOD-2 (Mn-SOD) (Watabe et al. <xref ref-type="bibr" rid="CR166">1997</xref>; Cao et al. <xref ref-type="bibr" rid="CR21">2007</xref>). Prx-3 protects against peroxynitrite anions (Hattori et al. <xref ref-type="bibr" rid="CR55">2003</xref>; see Hanschmann et al. <xref ref-type="bibr" rid="CR53">2013</xref>), and it is expressed heterogeneously, correlating with a regional sensitivity to excitotoxic damage (Hattori et al. <xref ref-type="bibr" rid="CR55">2003</xref>; Aon-Bertolino et al. <xref ref-type="bibr" rid="CR8">2011</xref>).</p></sec><sec id="Sec5"><title>Current Brain-Protecting Strategies</title><p id="Par75">Therapeutic options against the long-term effects of PA are limited and mainly based on hypothermia, which provides protection only if initiated soon after the insult (Thoresen et al. <xref ref-type="bibr" rid="CR150">2013</xref>). No consensus on clinical protocols has been achieved yet, and the advantages and disadvantages of head or whole body cooling are still debated, including safety and developmental considerations (Committee on Fetus &#x00026; Newborn <xref ref-type="bibr" rid="CR27">2014</xref>; Allen <xref ref-type="bibr" rid="CR4">2014</xref>; Shankaran et al. <xref ref-type="bibr" rid="CR140">2014</xref>; Sabir and Cowan <xref ref-type="bibr" rid="CR135">2015</xref>; Ahearne et al. <xref ref-type="bibr" rid="CR2">2016</xref>).</p></sec><sec id="Sec6"><title>Hypothermia</title><p id="Par76">There is compelling clinical evidence that cerebral hypothermia improves the neurodevelopmental outcome when applied to infants with moderate to severe hypoxic-ischaemic encephalopathy (HIE), before the onset of a secondary deterioration phase (Edwards et al. <xref ref-type="bibr" rid="CR36">2010</xref>; Guillet et al. <xref ref-type="bibr" rid="CR58">2012</xref>; Shankaran et al. <xref ref-type="bibr" rid="CR139">2012</xref>; see Wassink et al. <xref ref-type="bibr" rid="CR165">2014</xref>; Vanlandingham et al. <xref ref-type="bibr" rid="CR155">2015</xref>). This has led to a recommendation supported by the <italic>European Resuscitation Council</italic> that any new therapeutic approach dealing with neonatal encephalopathy should be compared to the effect produced by hypothermia (Davidson et al. <xref ref-type="bibr" rid="CR32">2015</xref>; Gunn and Thoresen <xref ref-type="bibr" rid="CR51">2015</xref>).</p><p id="Par77">As mentioned above, the current hypothermia protocols are still insufficient (Allen <xref ref-type="bibr" rid="CR4">2014</xref>), and a main drawback is the existence of a narrow therapeutic window (Odd et al. <xref ref-type="bibr" rid="CR111">2009</xref>; Sabir and Cowan <xref ref-type="bibr" rid="CR135">2015</xref>; Ahearne et al. <xref ref-type="bibr" rid="CR2">2016</xref>). The rationale of hypothermia is graded reduction of cerebral metabolism, about 5% for every degree Celsius of temperature reduction (Laptook et al. <xref ref-type="bibr" rid="CR85">1995</xref>; Erecinska et al. <xref ref-type="bibr" rid="CR39">2003</xref>). Cooling also reduces post-depolarization release of excitatory amino acids during hypoxia-ischaemia, both in newborn (Thoresen et al. <xref ref-type="bibr" rid="CR149">1997</xref>) and in adult (Nakashima and Todd <xref ref-type="bibr" rid="CR107">1996</xref>) subjects. Microdialysis experiments showed that hypothermia initiated immediately after hypoxia-ischaemia in newborn piglets was associated with reduced levels of excitatory amino acids and reduced NO efflux compared to the control condition (Thoresen et al. <xref ref-type="bibr" rid="CR149">1997</xref>; Rostami et al. <xref ref-type="bibr" rid="CR134">2013</xref>), in agreement with evidence that glutamate antagonists can also prevent events occurring in the early recovery phase following hypoxia-ischaemia, before failure of mitochondrial function takes place, but only when the effect of the antagonist is associated with hypothermia (Nurse and Cobertt <xref ref-type="bibr" rid="CR110">1996</xref>).</p></sec><sec id="Sec7"><title>PARP-1 Overactivation</title><p id="Par78">PARP-1 plays a critical role during development, and is activated upon any threat to the genome, either for its repair or for initiating cell death signalling to protect its integrity. Indeed, PARP-1 overactivation elicits a NMDAR-dependent, caspase-independent, parthanatos-like cell death programme (Wang et al. <xref ref-type="bibr" rid="CR164">2016</xref>) and PA increases PARP-1 activity in the rat brain shortly after the insult (Allende-Castro et al. <xref ref-type="bibr" rid="CR5">2012</xref>), triggering a signalling cascade leading to nuclear translocation of the NF-&#x003ba;B subunit p65 and the expression of the pro-inflammatory proteins IL-1&#x003b2; and TNF-&#x003b1;, increasing cell death (Neira-Pe&#x000f1;a et al. <xref ref-type="bibr" rid="CR108">2015</xref>). Such effects are prevented by the PARP-1 inhibitor nicotinamide, supporting previous reports showing similar protection against neuronal death (Klawitter et al. <xref ref-type="bibr" rid="CR78">2007</xref>), brain dopaminergic dysfunction (Bustamante et al. <xref ref-type="bibr" rid="CR20">2007</xref>), and behavioural deficits (Simola et al. <xref ref-type="bibr" rid="CR142">2008</xref>; Morales et al. <xref ref-type="bibr" rid="CR104">2010</xref>) assessed 2&#x02013;6&#x000a0;months after the perinatal insult. PARP-1 inhibition attenuates nNOS activation and reduces cell death induced by oxidative conditions (Pieper et al. <xref ref-type="bibr" rid="CR120">2000</xref>; Klawitter et al. <xref ref-type="bibr" rid="CR78">2007</xref>), restoring metabolic functions including energy production (Chen et al. <xref ref-type="bibr" rid="CR25">2009</xref>; Xu et al. <xref ref-type="bibr" rid="CR169">2009</xref>). Nicotinamide, as an NAD<sup>+</sup> precursor, probably protects against the metabolic cascade elicited by the primary insult, avoiding NAD<sup>+</sup> exhaustion and the energy crisis.</p><p id="Par79">While the hypothesis of PARP-1 inhibition is promising, it has yet to reach a consensus in order to attempt a clinical trial, in part because nicotinamide does not provide full protection against the effects elicited by PA. Nicotinamide prevents vulnerability to recurrent metabolic insults, but mainly in the substantia nigra, with only minor effects in the neocortex and neostriatum (Neira-Pe&#x000f1;a et al. <xref ref-type="bibr" rid="CR108">2015</xref>; Perez-Lobos et al. <xref ref-type="bibr" rid="CR116">2017</xref>). The issue of analogues, precursors, or metabolites of nicotinamide is attractive (Trammell et al. <xref ref-type="bibr" rid="CR152">2016</xref>), recently discussed in relation to nicotinamide riboside, which improves mitochondrial and stem cell function, prolonging the life span of mice (Zhang et al. <xref ref-type="bibr" rid="CR170">2016</xref>).</p><p id="Par80">Nicotinamide mononucleotide has been shown to be superior to nicotinamide as a precursor of NAD<sup>+</sup> (Kawamura et al. <xref ref-type="bibr" rid="CR75">2016</xref>), leading to the proposal that nicotinamide mononucleotide protects from energy deficits by restoring NAD<sup>+</sup> and ATP levels, reducing ROS accumulation (Wang et al. <xref ref-type="bibr" rid="CR164">2016</xref>). The oral bioavailability of nicotinamide mononucleotide has been reported, and this intermediate mitigates age-associated physiological decline in mice without any obvious toxicity or deleterious effects, enhancing mitochondrial oxidative metabolism and preventing mitonuclear protein imbalance (Mills et al. <xref ref-type="bibr" rid="CR100">2016</xref>). It is not yet known whether nicotinamide riboside or mononucleotide can also decrease PARP-1 overactivation, or whether they can prevent the long-term consequences of PA.</p></sec><sec id="Sec8"><title>Glutamate Excitotoxicity</title><p id="Par81">The involvement of glutamate in excitotoxicity-mediated damage induced by metabolic insults, including stroke, ischaemia, and hypoxia, led to the strategy of treating with selective high-affinity NMDA and/or AMPA antagonists, all of which failed in clinical trials (Cheng et al. <xref ref-type="bibr" rid="CR26">2004</xref>). The classical non-competitive NMDAR antagonist dizocilpine (MK-801) gave hope for death prevention following PA (Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR56">1993</xref>, <xref ref-type="bibr" rid="CR57">1994</xref>; Engidawork et al. <xref ref-type="bibr" rid="CR38">2001</xref>), but it was largely surpassed by hypothermia. It was also discussed whether the minor protection provided by MK-801 is explained by a hypothermia-induced effect (Buchan and Pulsinelli <xref ref-type="bibr" rid="CR19">1990</xref>; see Alkan et al. <xref ref-type="bibr" rid="CR3">2001</xref>; Makarewicz et al. <xref ref-type="bibr" rid="CR93">2014</xref>).</p><p id="Par82">Several glutamate transporter proteins are expressed by astrocytes, mainly GLAST (EAAT1) and GLT-1 (EAAT2) subtypes, responsible for the majority of glutamate uptake (see Robinson and Jackson <xref ref-type="bibr" rid="CR131">2016</xref>), providing a target for increasing or decreasing extracellular glutamate levels (Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR58">1996</xref>). <italic>N</italic>-Acetylcysteine, a clinically established antioxidant, has been shown to activate the cystine/glutamate antiporter, modulating extracellular glutamate levels (Danbolt <xref ref-type="bibr" rid="CR30">2001</xref>; see Berk et al. <xref ref-type="bibr" rid="CR14">2013</xref>). The actual direction of the transport of cystine or glutamate depends upon the intracellular and extracellular concentration of the respective molecules. Several clinical studies have shown that <italic>N</italic>-acetylcysteine is well tolerated, promising a role for the treatment of a number of neuropsychiatric disorders (Wink et al. <xref ref-type="bibr" rid="CR167">2016</xref>; see Berk et al. <xref ref-type="bibr" rid="CR14">2013</xref>). In the brain, <italic>N</italic>-acetylcysteine is deacetylated and oxidised to cystine, which is reduced back to cysteine when taken up by the cells, playing a role in the synthesis of glutathione (GSH) (Bavarsad Shahripour et al. <xref ref-type="bibr" rid="CR12">2014</xref>). Thus, <italic>N</italic>-acetylcysteine is perhaps an option to be tested in the present model (see Quintanilla et al. <xref ref-type="bibr" rid="CR128">2016</xref>).</p></sec><sec id="Sec9"><title>Memantine as a Lead for a Neonatal Protecting Strategy</title><p id="Par83">D145 (1-amino-3,5-dimethyladamantane), better known as memantine, was first proposed as a putative anti-parkinsonian drug in the 1980s, since it induced rotational behaviour in unilaterally 6-OHDA-lesioned animals with a profile mimicking that of <sc>d</sc>-amphetamine and apomorphine, indirect and direct dopamine agonists respectively (Danysz et al. <xref ref-type="bibr" rid="CR31">1997</xref>; see Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR60">2007</xref>, <xref ref-type="bibr" rid="CR61">2010</xref>). This was confirmed by Seeman et al. (<xref ref-type="bibr" rid="CR138">2008</xref>), demonstrating the action of memantine on dopamine D<sub>2</sub> receptors. Nevertheless, the main pharmacodynamic feature supporting a clinical application in stroke, ischaemia, or neurodegenerative disorders was based on the observation that memantine is a low-affinity, use-dependent, NMDAR channel blocker with fast kinetics, not interfering with normal synaptic transmission, but blocking NMDAR only when it is overstimulated (Volbracht et al. <xref ref-type="bibr" rid="CR160">2006</xref>; Rammes et al. <xref ref-type="bibr" rid="CR129">2008</xref>). Memantine is considered at present as a prototype for targeting extrasynaptic NMDR activity (Garcia-Munoz et al. <xref ref-type="bibr" rid="CR45">2015</xref>; Johnson et al. <xref ref-type="bibr" rid="CR73">2015</xref>).</p><p id="Par84">Memantine is well tolerated and has a low incidence of adverse effects (Kavirajan <xref ref-type="bibr" rid="CR74">2009</xref>), also inducing mild hypothermia (Krieglstein et al. <xref ref-type="bibr" rid="CR82">1997</xref>), a feature further supporting its clinical potential (see Rammes et al. <xref ref-type="bibr" rid="CR129">2008</xref>). Memantine has been approved by the European Medicine Agency and the Food and Drug Administration (FDA-USA) for the treatment of moderately severe Alzheimer&#x02019;s disease (2006). It has been reported that memantine can reduce functional and morphological sequelae induced by ischaemia (Block and Schwarz <xref ref-type="bibr" rid="CR16">1996</xref>; Chen et al. <xref ref-type="bibr" rid="CR24">1998</xref>; Volbracht et al. <xref ref-type="bibr" rid="CR160">2006</xref>), possibly by selectively blocking extrasynaptic NMDAR (Chen et al. <xref ref-type="bibr" rid="CR23">1992</xref>; Xia et al. <xref ref-type="bibr" rid="CR168">2010</xref>; Garcia-Munoz et al. <xref ref-type="bibr" rid="CR45">2015</xref>). Memantine has also been evaluated for efficacy in children with pervasive developmental disorders, including leukomalacia, while there is still concern about increasing constitutive apoptosis, recommending further preclinical investigation (Manning et al. <xref ref-type="bibr" rid="CR94">2011</xref>).</p><p id="Par85">An important issue refers to whether memantine prevents the excitotoxic cascade elicited by PA. This question merits investigation, either with memantine alone and/or together with the PARP-1 inhibitor nicotinamide, to assess prevention of the short- and long-term effects elicited by PA, profiting also from the mild hypothermia induced by memantine (Krieglstein et al. <xref ref-type="bibr" rid="CR82">1997</xref>; Gunn and Thoresen <xref ref-type="bibr" rid="CR51">2015</xref>). Memantine can improve mitochondrial respiration, preventing mitochondrial permeabilization during the secondary (reperfusion) phase following hypoxic-ischaemic injury (Block and Schwarz <xref ref-type="bibr" rid="CR16">1996</xref>; Chen et al. <xref ref-type="bibr" rid="CR24">1998</xref>; Pirinen et al. <xref ref-type="bibr" rid="CR121">2014</xref>; Olah et al. <xref ref-type="bibr" rid="CR112">2015</xref>), in agreement with a pivotal role of extrasynaptic NMDA receptors in the effects elicited during the re-oxygenation phase following hypoxia.</p><p id="Par86">The chemical structure of memantine (3,5-dimethyltricyclo[3.3.1.1<sup>3,7</sup>]decan-1-amine) allows additional groups to be attached to increase selectivity, improving its pharmacodynamic and/or pharmacokinetic properties. Hence, nitromemantine has been synthesised, by attaching a nitrate group to produce 3-amino-5,7-diethyladamantan-1-yl nitrate. This NO source improved efficacy as a neuroprotectant, compared to that provided by memantine, by nitrosating a redox-mediated regulatory site on the extrasynaptic NMDA receptor (Lipton <xref ref-type="bibr" rid="CR86">2006</xref>; Takahashi et al. <xref ref-type="bibr" rid="CR147">2015</xref>; see Nakamura and Lipton <xref ref-type="bibr" rid="CR106">2016</xref>).</p><p id="Par87">Hypothermia and excitatory amino acid blockage can provide a potent synergism for prevention of the secondary energetic mitochondrial-related failure associated with PA. Nevertheless, many of the compounds used for blocking the initial phases of injury, excitotoxicity, and oxidative stress elicited by hypoxic-ischaemic encephalopathy failed, also because of blockage of normal functions associated to glutamatergic signalling. MK-801 decreases death following PA (Peruche and Krieglstein <xref ref-type="bibr" rid="CR118">1993</xref>; Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR56">1993</xref>, <xref ref-type="bibr" rid="CR57">1994</xref>), but it also induces apoptosis, impairing brain development in rats (Ikonomidou et al. <xref ref-type="bibr" rid="CR66">1999</xref>).</p></sec><sec id="Sec10"><title>Vulnerability to Recurrent Metabolic Insults</title><p id="Par88">Neonatal metabolic insults may lead to immediate and/or delayed consequences, with clinical onset at different developmental stages. Understanding the sequence of these events is still sketchy. Nevertheless, it has been discussed that metabolic insults occurring at birth (a first hit) can prime development, increasing the vulnerability to recurrent (secondary and tertiary hit) insults, ultimately challenging postnatal development and maturity. In humans, PA is a risk factor for several psychiatric disorders, including learning deficits and schizophrenia. Conversely, in rodents, PA is associated with delayed cell death, dopamine and histamine transmission deficits and behavioural impairments assessed at adulthood, affecting learning, spatial, and non-spatial memory and anxiety (Simola et al. <xref ref-type="bibr" rid="CR142">2008</xref>; Morales et al. <xref ref-type="bibr" rid="CR104">2010</xref>; Galeano et al. <xref ref-type="bibr" rid="CR43">2011</xref>, <xref ref-type="bibr" rid="CR44">2015</xref>; Flores-Balter et al. <xref ref-type="bibr" rid="CR41">2016</xref>; Tapia-Bustos et al. <xref ref-type="bibr" rid="CR148">2017</xref>). The idea of progressive dysfunction and &#x0201c;first&#x0201d; and successive hit sequences, triggering and perpetuating pathophysiological conditions and/or diseases, has recently been discussed (Marriott et al. <xref ref-type="bibr" rid="CR95">2017</xref>; Israel et al. <xref ref-type="bibr" rid="CR69">2017</xref>). In agreement with this, it was recently reported that PA implies a long-term energy deficit and oxidative stress, evaluated by the ADP/ATP and GSH/GSSG ratio, respectively, prevented by nicotinamide (Perez-Lobos et al. <xref ref-type="bibr" rid="CR116">2017</xref>). Figure <xref rid="Fig1" ref-type="fig">1</xref> shows the effect of PA and a recurrent metabolic insult (1&#x000a0;mM H<sub>2</sub>O<sub>2</sub>) on ADP/ATP (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a), GSH/GSSG (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b), and potassium ferricyanide-reducing power (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c) measurements on entire sample homogenates from triple organotypic cultures from caesarean-delivered and asphyxia-exposed rat neonates, making it evident that PA produces a permanent energy deficit (increased ADP/ATP ratio) and oxidative stress (decreased GSH/GSSG ratio), as well as a permanent deficit in reducing antioxidant power, increasing vulnerability to recurrent insults (Perez-Lobos et al. <xref ref-type="bibr" rid="CR116">2017</xref>)<fig id="Fig1"><label>Fig. 1</label><caption><p>ADP/ATP (<bold>a</bold>), GSH/GSSG (<bold>b</bold>), and )<bold>c</bold>) potassium ferricyanide-reducing power measurements on entire sample homogenates from triple organotypic cultures. <bold>a</bold> ADP/ATP ratio observed in cultures at 21&#x000a0;days in vitro (DIV) from caesarean-delivered (controls; CS) (<italic>open columns</italic>) and asphyxia-exposed (AS) (hatched columns) rat neonates (P2) (means&#x000a0;&#x000b1;&#x000a0;SEM; <italic>n</italic>&#x000a0;=&#x000a0;6, for each experimental groups). <bold>b</bold> GSH/GSSG ratio. <bold>c</bold> Potassium ferricyanide-reducing power. <sup>a</sup>
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05 for the effect of asphyxia (CS&#x000a0;+&#x000a0;Sal versus AS&#x000a0;+&#x000a0;Sal); <sup>b</sup>
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05 for the effect of H<sub>2</sub>O<sub>2</sub> (CS&#x000a0;+&#x000a0;Sal&#x000a0;+&#x000a0;0&#x000a0;mM H<sub>2</sub>O<sub>2</sub> versus CS&#x000a0;+&#x000a0;Sal&#x000a0;+&#x000a0;1&#x000a0;mM H<sub>2</sub>O<sub>2</sub>, or AS&#x000a0;+&#x000a0;Sal&#x000a0;+&#x000a0;0&#x000a0;mM H<sub>2</sub>O<sub>2</sub> versus AS&#x000a0;+&#x000a0;Sal&#x000a0;+&#x000a0;1&#x000a0;mM H<sub>2</sub>O<sub>2</sub>). <sup>c</sup>
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05, for the effect of nicotinamide (NAM) (CS&#x000a0;+&#x000a0;Sal&#x000a0;+&#x000a0;0&#x000a0;mM H<sub>2</sub>O<sub>2</sub> versus CS&#x000a0;+&#x000a0;NAM&#x000a0;+&#x000a0;0&#x000a0;mM H<sub>2</sub>O<sub>2</sub>; CS&#x000a0;+&#x000a0;Sal&#x000a0;+&#x000a0;1&#x000a0;mM H<sub>2</sub>O<sub>2</sub> versus CS&#x000a0;+&#x000a0;NAM&#x000a0;+&#x000a0;1&#x000a0;mM H<sub>2</sub>O<sub>2</sub>; AS&#x000a0;+&#x000a0;Sal&#x000a0;+&#x000a0;0&#x000a0;mM H<sub>2</sub>O<sub>2</sub> versus AS&#x000a0;+&#x000a0;NAM&#x000a0;+&#x000a0;0&#x000a0;mM H<sub>2</sub>O<sub>2</sub>; AS&#x000a0;+&#x000a0;Sal&#x000a0;+&#x000a0;1&#x000a0;mM H<sub>2</sub>O<sub>2</sub> versus AS&#x000a0;+&#x000a0;NAM&#x000a0;+&#x000a0;1&#x000a0;mM H<sub>2</sub>O<sub>2</sub>) (data from Perez-Lobos et al. <xref ref-type="bibr" rid="CR116">2017</xref>)</p></caption><graphic xlink:href="12640_2017_9795_Fig1_HTML" id="MO1"/></fig>
</p></sec><sec id="Sec11"><title>Conclusions</title><p id="Par89">The present review focuses on the short- and long-term metabolic cascades triggered by PA, identifying pathways that can explain long-term vulnerability and clinical consequences. The Karolinska Institutet model of PA has recently been discussed by a review summarising 25&#x000a0;years of research on global asphyxia in the immature rat brain (Barkhuizen et al. <xref ref-type="bibr" rid="CR10">2017</xref>).</p><p id="Par90">PA is still a prominent clinical issue with few therapeutic alternatives preventing its long-term consequences. We have established a unique experimental model of global PA in rats occurring at the time of delivery, identifying relevant targets responsible for metabolic cascades leading to short- and long-term effects, evaluated by in vivo and in vitro experiments (see Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR62">2011</xref>, <xref ref-type="bibr" rid="CR63">2014</xref>). The model is a referent among those used for studying progressive neurological dysfunction originating early in life (Marriot et al. <xref ref-type="bibr" rid="CR95">2017</xref>). PA constitutes a model of neural damage and regeneration for many other conditions such as stroke, where hypoxia/ischaemia is often followed by re-oxygenation and injury.</p><p id="Par91">The discussed model has been compared to that of hypoxia/ischaemia proposed by Rice et al. (<xref ref-type="bibr" rid="CR130">1981</xref>) (Vannucci and Vannucci <xref ref-type="bibr" rid="CR156">1997</xref>; Vannucci et al. <xref ref-type="bibr" rid="CR157">1996</xref>, <xref ref-type="bibr" rid="CR158">2005</xref>), marshalling the fact that the reviewed model is performed with on-term and not with neonates at P7, the former being premature when compared to the neonatal human brain. The prematurity of the neonatal rat brain has been a subject of controversy, arguing that the degree of maturity depends upon the tissue and the functions selected for comparison (Herrera-Marschitz et al. <xref ref-type="bibr" rid="CR63">2014</xref>). Further, the model of Vannucci and collaborators involves ligation of vessels, resulting in a pathophysiology equivalent to focal stroke, not necessarily triggered by global asphyxia (Fellman and Raivio <xref ref-type="bibr" rid="CR40">1997</xref>). The here discussed model (i) is a good mimic of human delivery (Romero et al. <xref ref-type="bibr" rid="CR132">2006</xref>); (ii) it is largely non-invasive, not involving vessel ligation, ischaemia, or exposure of pulmonary breathing animals to N<sub>2</sub> inhalation chambers (Fellman and Raivio <xref ref-type="bibr" rid="CR40">1997</xref>); (iii) it allows evaluation of short- and long-term consequences of the insult, monitored in the same preparation (Kohlhauser et al. <xref ref-type="bibr" rid="CR80">1999a</xref>, <xref ref-type="bibr" rid="CR79">b</xref>; Simola et al. <xref ref-type="bibr" rid="CR142">2008</xref>; Morales et al. <xref ref-type="bibr" rid="CR104">2010</xref>); (iv) it is highly reproducible among laboratories (Lubec et al. <xref ref-type="bibr" rid="CR91">1997a</xref>, <xref ref-type="bibr" rid="CR90">b</xref>); and (v) it is considered as a reference by worldwide leading labs (see Wassink et al. <xref ref-type="bibr" rid="CR165">2014</xref>; Gunn and Thoresen <xref ref-type="bibr" rid="CR51">2015</xref>). Furthermore, (vi) the model is unique in providing a bridge between in vivo and in vitro experiments, based on the same preparation. Indeed, foetuses and neonates can be used to prepare organotypic cultures, complementing and/or allowing experiments with bioethical restrictions when performed in vivo, such as exposing surviving neonates to a recurrent insult (Perez-Lobos et al. <xref ref-type="bibr" rid="CR116">2017</xref>).</p><p id="Par92">The organotypic culture model originally developed by BH Gahwiler in Zurich (<xref ref-type="bibr" rid="CR46">1981</xref>) was validated by Plenz and Kitai (<xref ref-type="bibr" rid="CR123">1996a</xref>, <xref ref-type="bibr" rid="CR124">b</xref>; Plenz et al. <xref ref-type="bibr" rid="CR125">1998</xref>), as a powerful tool for studying rat basal ganglia neurocircuitries. In this model, the pattern of neuronal innervation and neurocircuitry formation is moved back to an earlier stage, providing an opportunity to monitor under the microscope how neurites and processes look for their corresponding targets, establishing innervation plexuses, showing electrophysiological (Plenz and Kitai <xref ref-type="bibr" rid="CR124">1996b</xref>) and neurochemical (Gomez-Urquijo et al. <xref ref-type="bibr" rid="CR48">1999</xref>) features similar to those observed in vivo. The model has been used to demonstrate the effect of PA on the number and branching of tyrosine-hydroxylase-positive neurons, illustrating the vulnerability of the dopaminergic systems to PA (Morales et al. <xref ref-type="bibr" rid="CR102">2003</xref>; Klawitter et al. <xref ref-type="bibr" rid="CR77">2005</xref>, <xref ref-type="bibr" rid="CR78">2007</xref>). We have recently reported that the organotypic model allows evaluation of the effect of PA on postnatal vulnerability to oxidative stress, demonstrating an additive effect to that produced by PA on cells with neuronal and glial phenotype, prevented by systemic nicotinamide treatment 1&#x000a0;h after birth (Perez-Lobos et al. <xref ref-type="bibr" rid="CR116">2017</xref>).</p><p id="Par93">PA provides a framework to address a fundamental issue affecting long-term CNS plasticity. The perinatal insult triggers a domino-like sequence of events making the developing individual vulnerable to recurrent adverse conditions, decreasing his/her coping repertoire because of a relevant insult occurring at birth (Marriott et al. <xref ref-type="bibr" rid="CR95">2017</xref>). The issue of the short- and long-term consequences of PA has heuristic relevance, since PA implicates a long-term biological vulnerability that fully depends on the severity of an insult occurring at birth, independently of any genetic or clinical predisposition (Sahin and Sur <xref ref-type="bibr" rid="CR136">2015</xref>; Jain et al. <xref ref-type="bibr" rid="CR71">2017</xref>). Indeed, by definition, PA (an environmentally dependent variable) refers to an unexpected interruption of oxygen at the time of delivery, when labour has already begun. Therefore, no genetic factor, malformation, or prematurity is included in the clinical entity of PA, which is defined as a specific metabolic/energetic insult related, first, to the delay and/or interruption of autonomous breathing, and, second, to re-oxygenation, a requirement for survival.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ADP</term><def><p id="Par3">Adenosine diphosphate</p></def></def-item><def-item><term>AIF</term><def><p id="Par4">Apoptosis inducing factor</p></def></def-item><def-item><term>AM</term><def><p id="Par5">Calcein-acetoxymethyl ester</p></def></def-item><def-item><term>AMPA</term><def><p id="Par6">&#x003b1;-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p></def></def-item><def-item><term>AS</term><def><p id="Par7">Asphyxia-exposed rats</p></def></def-item><def-item><term>ATP</term><def><p id="Par8">Adenosine triphosphate</p></def></def-item><def-item><term>BCA</term><def><p id="Par9">Bicinchoninic acid</p></def></def-item><def-item><term>Bcl-2</term><def><p id="Par10">B-cell lymphoma 2</p></def></def-item><def-item><term>Bnip3</term><def><p id="Par11">BCL2-interacting protein 3</p></def></def-item><def-item><term>CNS</term><def><p id="Par12">Central nervous system</p></def></def-item><def-item><term>CS</term><def><p id="Par13">Caesarean-delivered rats</p></def></def-item><def-item><term>Cx</term><def><p id="Par14">Neocortex</p></def></def-item><def-item><term>COX-2</term><def><p id="Par15">Cyclooxygenase-2</p></def></def-item><def-item><term>D145</term><def><p id="Par16">1-Amino-3,5-dimethyladamantane</p></def></def-item><def-item><term>DAPI</term><def><p id="Par17">4&#x02032;6-Diamidino-2-phenylindole</p></def></def-item><def-item><term>DIV</term><def><p id="Par18">Days in vitro</p></def></def-item><def-item><term>DNA</term><def><p id="Par19">Deoxyribonucleic acid</p></def></def-item><def-item><term>DTNB</term><def><p id="Par20">5,5&#x02032;-Dithiobis-2-nitrobenzoic acid</p></def></def-item><def-item><term>EthD-1</term><def><p id="Par21">Ethidium-homodimer-1</p></def></def-item><def-item><term>FDA</term><def><p id="Par22">Food and Drug Administration</p></def></def-item><def-item><term>G</term><def><p id="Par23">Gestation day</p></def></def-item><def-item><term>GFAP</term><def><p id="Par24">Glial fibrillary acidic protein</p></def></def-item><def-item><term>GLAST (EAAT1)</term><def><p id="Par25">Glutamate aspartate transport</p></def></def-item><def-item><term>GLT-1 (EAAT2)</term><def><p id="Par26">Glutamate transport-1</p></def></def-item><def-item><term>GPx</term><def><p id="Par27">Glutathione peroxidase</p></def></def-item><def-item><term>GSH</term><def><p id="Par28">Reduced glutathione</p></def></def-item><def-item><term>GSSG</term><def><p id="Par29">Oxidised glutathione</p></def></def-item><def-item><term>H<sub>2</sub>O<sub>2</sub></term><def><p id="Par30">Hydrogen peroxide</p></def></def-item><def-item><term>HIE</term><def><p id="Par31">Hypoxic-ischaemic encephalopathy</p></def></def-item><def-item><term>HIF-1&#x003b1;</term><def><p id="Par32">Hypoxia-induced factor-1&#x003b1;</p></def></def-item><def-item><term>i.p.</term><def><p id="Par33">Intraperitoneal</p></def></def-item><def-item><term>IL-1&#x003b2;</term><def><p id="Par34">Interleukin 1&#x003b2;</p></def></def-item><def-item><term>MAP-2</term><def><p id="Par35">Microtubule-associated protein-2</p></def></def-item><def-item><term>MK-801</term><def><p id="Par36">Dizocilpine</p></def></def-item><def-item><term>NAC</term><def><p id="Par37">
<italic>N</italic>-Acetylcysteine</p></def></def-item><def-item><term>NAD<sup>+</sup></term><def><p id="Par38">Nicotinamide adenine dinucleotide</p></def></def-item><def-item><term>NADPH</term><def><p id="Par39">Nicotinamide adenine dinucleotide phosphate</p></def></def-item><def-item><term>NAM</term><def><p id="Par40">Nicotinamide, niacinamide, vitamin B3</p></def></def-item><def-item><term>NF-&#x003ba;B</term><def><p id="Par41">Nuclear factor kappa-light-chain-enhancer of activated B cells</p></def></def-item><def-item><term>Nix</term><def><p id="Par42">BCL2/adenovirus E1B-interacting protein 3-like</p></def></def-item><def-item><term>NMDAR</term><def><p id="Par43">N-Methyl-<sc>d</sc>-aspartate receptor</p></def></def-item><def-item><term>nNOS</term><def><p id="Par44">Neuronal nitric oxide synthase</p></def></def-item><def-item><term>NO</term><def><p id="Par45">Nitric oxide</p></def></def-item><def-item><term>Noxa</term><def><p id="Par46">Phorbol-12-myristate-13-acetate-induced protein 1</p></def></def-item><def-item><term>6-OHDA</term><def><p id="Par47">6-Hydroxydopamine</p></def></def-item><def-item><term>ONOO</term><def><p id="Par48">Peroxynitrite anion</p></def></def-item><def-item><term>P</term><def><p id="Par49">Postnatal day</p></def></def-item><def-item><term>PA</term><def><p id="Par50">Perinatal asphyxia</p></def></def-item><def-item><term>PARP-1</term><def><p id="Par51">Poly(ADP-ribose) polymerase-1</p></def></def-item><def-item><term>Prx-3</term><def><p id="Par52">Peroxyredoxin-3</p></def></def-item><def-item><term>pVHL</term><def><p id="Par53">von Hippel-Lindau tumour-suppressing factor</p></def></def-item><def-item><term>RFU</term><def><p id="Par54">Relative fluorescence units</p></def></def-item><def-item><term>RNS</term><def><p id="Par55">Reactive nitrogen species</p></def></def-item><def-item><term>ROS</term><def><p id="Par56">Reactive oxygen species</p></def></def-item><def-item><term>TNF-&#x003b1;</term><def><p id="Par57">Tumour necrosis factor alpha</p></def></def-item><def-item><term>TH</term><def><p id="Par58">Tyrosine hydroxylase</p></def></def-item><def-item><term>TUNEL</term><def><p id="Par59">Terminal deoxynucleotidyl transferase dUTP nick end labelling</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>Contract grant sponsors: FONDECYT-Chile (#1180064); Millennium Scientific Initiative (BNI P09-015-F); MH-Marschitz foundation, Sweden. RPL (#21130739), CLR (#21140281), ATB (#21151232), and EP (#21171433) are CONICYT-Chile fellows. VVM was a MECESUP-Chile fellow (UCH0704).</p></ack><notes notes-type="COI-statement"><title>Compliance with Ethical Standards</title><sec id="FPar1"><title>Conflict of Interest</title><p id="Par94">The authors declare that they have no conflict of interest.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramov</surname><given-names>AY</given-names></name><name><surname>Duchen</surname><given-names>MR</given-names></name></person-group><article-title>Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity</article-title><source>Biochim Biophysis Acta</source><year>2008</year><volume>1777</volume><fpage>953</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2008.04.017</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahearne</surname><given-names>CE</given-names></name><name><surname>Boylan</surname><given-names>GB</given-names></name><name><surname>Murray</surname><given-names>DM</given-names></name></person-group><article-title>Short and long term prognosis in perinatal asphyxia: an update</article-title><source>World J Clin Pediatr</source><year>2016</year><volume>5</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.5409/wjcp.v5.i1.67</pub-id><?supplied-pmid 26862504?><pub-id pub-id-type="pmid">26862504</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkan</surname><given-names>T</given-names></name><name><surname>Kahveci</surname><given-names>N</given-names></name><name><surname>Buyukusal</surname><given-names>L</given-names></name><name><surname>Korfali</surname><given-names>E</given-names></name><name><surname>Ozluk</surname><given-names>K</given-names></name></person-group><article-title>Neuroprotective effect of MK-801 and hypothermia used alone and in combination in hypoxic-ischemic brain injury in neonatal rats</article-title><source>Arch Physiol Biochem</source><year>2001</year><volume>109</volume><fpage>135</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1076/apab.109.2.135.4271</pub-id><?supplied-pmid 11780774?><pub-id pub-id-type="pmid">11780774</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>KA</given-names></name></person-group><article-title>Moderate hypothermia: is selective head cooling or whole body cooling better?</article-title><source>Adv Neonatal Care</source><year>2014</year><volume>14</volume><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1097/ANC.0000000000000059</pub-id><?supplied-pmid 24675631?><pub-id pub-id-type="pmid">24675631</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allende-Castro</surname><given-names>C</given-names></name><name><surname>Espina-Marchant</surname><given-names>P</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Rojas-Mancilla</surname><given-names>E</given-names></name><name><surname>Neira</surname><given-names>T</given-names></name><name><surname>Gutierrez-Hernandez</surname><given-names>MA</given-names></name><name><surname>Esmar</surname><given-names>D</given-names></name><name><surname>Valdes</surname><given-names>JL</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Gebicke-Haerter</surname><given-names>PJ</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Further studies on the hypothesis of PARP-1 inhibition as strategy for lessening the long-term effects produced by perinatal asphyxia: effects of nicotinamide and theophylline on PARP-1 activity in brain and peripheral tissue</article-title><source>Neurotox Res</source><year>2012</year><volume>22</volume><fpage>79</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1007/s12640-012-9310-2</pub-id><?supplied-pmid 22311271?><pub-id pub-id-type="pmid">22311271</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>CM</given-names></name><name><surname>Swanson</surname><given-names>RA</given-names></name></person-group><article-title>Astrocyte glutamate transport: review of properties, regulation and physiological functions</article-title><source>Glia</source><year>2000</year><volume>32</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1002/1098-1136(200010)32:1&#x0003c;1::AID-GLIA10&#x0003e;3.0.CO;2-W</pub-id><?supplied-pmid 10975906?><pub-id pub-id-type="pmid">10975906</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>K</given-names></name><name><surname>Bjelke</surname><given-names>B</given-names></name><name><surname>Bolme</surname><given-names>P</given-names></name><name><surname>&#x000d6;gren</surname><given-names>S-&#x000d6;</given-names></name></person-group><article-title>Asphyxia-induced lesion of the rat hippocampus (CA1, CA3) and the nigro-striatal dopamine system. In: Gross J (ed) Hypoxia and ischemia. CNS. Wissenschafliche Publikationen der Humboldt-Universitat zu Berlin, B</article-title><source>Medizin</source><year>1992</year><volume>41</volume><fpage>71</fpage><lpage>76</lpage></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aon-Bertolino</surname><given-names>ML</given-names></name><name><surname>Romero</surname><given-names>JI</given-names></name><name><surname>Galeano</surname><given-names>P</given-names></name><name><surname>Holubec</surname><given-names>M</given-names></name><name><surname>Badorry</surname><given-names>MS</given-names></name><name><surname>Saraceno</surname><given-names>GE</given-names></name><name><surname>Hanschmann</surname><given-names>E-M</given-names></name><name><surname>Lillig</surname><given-names>CH</given-names></name><name><surname>Capani</surname><given-names>F</given-names></name></person-group><article-title>Thioredoxin and glutaredoxin system protein-immunocolocalization in the rat central nervous system</article-title><source>Biochemica et Biophysica Acta</source><year>2011</year><volume>1810</volume><fpage>93</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2010.06.011</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aschbacher</surname><given-names>K</given-names></name><name><surname>O'Donovan</surname><given-names>A</given-names></name><name><surname>Wolkowitz</surname><given-names>OM</given-names></name><name><surname>Dhabhar</surname><given-names>FS</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Epel</surname><given-names>E</given-names></name></person-group><article-title>Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity</article-title><source>Psychoneuroendocrinology</source><year>2013</year><volume>38</volume><fpage>1698</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2013.02.004</pub-id><?supplied-pmid 23490070?><pub-id pub-id-type="pmid">23490070</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkhuizen</surname><given-names>M</given-names></name><name><surname>van den Hove</surname><given-names>DLA</given-names></name><name><surname>Vles</surname><given-names>JSH</given-names></name><name><surname>Steinbusch</surname><given-names>HWM</given-names></name><name><surname>Kramer</surname><given-names>BW</given-names></name><name><surname>Gavilanes</surname><given-names>AWD</given-names></name></person-group><article-title>25 years of research on global asphyxia in the immature rat brain</article-title><source>Neurosci Biobehav Revs</source><year>2017</year><volume>75</volume><fpage>166</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2017.01.042</pub-id><pub-id pub-id-type="pmid">28161509</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basovich</surname><given-names>SN</given-names></name></person-group><article-title>The role of hypoxia in mental development and in the treatment of mental disorders: a review</article-title><source>Biosci Trends</source><year>2010</year><volume>4</volume><fpage>288</fpage><lpage>296</lpage><?supplied-pmid 21248426?><pub-id pub-id-type="pmid">21248426</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bavarsad Shahripour</surname><given-names>R</given-names></name><name><surname>Harigan</surname><given-names>MR</given-names></name><name><surname>Alexndrov</surname><given-names>AV</given-names></name></person-group><article-title>N-cetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities</article-title><source>Brain Behaviour</source><year>2014</year><volume>4</volume><fpage>108</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1002/brb3.208</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>NA</given-names></name></person-group><article-title>Poly (ADP-ribose) in the cellular response to DNA damage</article-title><source>Radiat Res</source><year>1985</year><volume>1001</volume><fpage>4</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.2307/3576299</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Malhi</surname><given-names>GS</given-names></name><name><surname>Gray</surname><given-names>LJ</given-names></name><name><surname>Dean</surname><given-names>OM</given-names></name></person-group><article-title>The promise of N-acetylcistein in neuropsychiatry</article-title><source>Trends Pharmacol Sci</source><year>2013</year><volume>34</volume><fpage>167</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2013.01.001</pub-id><?supplied-pmid 23369637?><pub-id pub-id-type="pmid">23369637</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjelke</surname><given-names>B</given-names></name><name><surname>Andersson</surname><given-names>K</given-names></name><name><surname>Ogren</surname><given-names>SO</given-names></name><name><surname>Bolme</surname><given-names>P</given-names></name></person-group><article-title>Asphyctic lesion: proliferation of tyrosine hydroxylase immunoreactive nerve cell bodies in the rat substantia nigra and functional changes in dopamine neurotransmission</article-title><source>Brain Res</source><year>1991</year><volume>543</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(91)91041-X</pub-id><?supplied-pmid 1675922?><pub-id pub-id-type="pmid">1675922</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Block</surname><given-names>F</given-names></name><name><surname>Schwarz</surname><given-names>M</given-names></name></person-group><article-title>Memantine reduces functional and morphological consequences induced by global ischemia in rats</article-title><source>Neurosci Lett</source><year>1996</year><volume>208</volume><fpage>41</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(96)12545-3</pub-id><?supplied-pmid 8731170?><pub-id pub-id-type="pmid">8731170</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonestroo</surname><given-names>HJ</given-names></name><name><surname>Nijboer</surname><given-names>CH</given-names></name><name><surname>van Velthoven</surname><given-names>CT</given-names></name><name><surname>Kavelaars</surname><given-names>A</given-names></name><name><surname>Hack</surname><given-names>CE</given-names></name><name><surname>van Bel</surname><given-names>F</given-names></name><name><surname>Heinjnen</surname><given-names>CJ</given-names></name></person-group><article-title>Cerebral and hepatic inflammatory response after neonatal hypoxia-ischemia in newborn rats</article-title><source>Dev Neurosci</source><year>2013</year><volume>35</volume><fpage>197</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1159/000346685</pub-id><?supplied-pmid 23689428?><pub-id pub-id-type="pmid">23689428</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruick</surname><given-names>RK</given-names></name></person-group><article-title>Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><fpage>9082</fpage><lpage>9087</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.16.9082</pub-id><?supplied-pmid 10922063?><pub-id pub-id-type="pmid">10922063</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchan</surname><given-names>A</given-names></name><name><surname>Pulsinelli</surname><given-names>WA</given-names></name></person-group><article-title>Hypothermia but not the N-methyl-D-aspartate antagonist MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia</article-title><source>J Neurosci</source><year>1990</year><volume>10</volume><fpage>311</fpage><lpage>316</lpage><?supplied-pmid 2405111?><pub-id pub-id-type="pmid">2405111</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Torres-Pereyra</surname><given-names>J</given-names></name><name><surname>Goiny</surname><given-names>M</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Nicotinamide prevents the effect of perinatal asphyxia on dopamine release evaluated with in vivo microdialysis 3 months after birth</article-title><source>Exp Brain Res</source><year>2007</year><volume>177</volume><fpage>358</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1007/s00221-006-0679-0</pub-id><?supplied-pmid 17051386?><pub-id pub-id-type="pmid">17051386</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Lindsay</surname><given-names>JG</given-names></name><name><surname>Isaacs</surname><given-names>NW</given-names></name></person-group><article-title>Mitochondrial peroxiredoxins</article-title><source>Subcell Biochem</source><year>2007</year><volume>44</volume><fpage>295</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1007/978-1-4020-6051-9_14</pub-id><?supplied-pmid 18084900?><pub-id pub-id-type="pmid">18084900</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>TS</given-names></name><name><surname>Cho</surname><given-names>CS</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Kang</surname><given-names>SW</given-names></name><name><surname>Rhee</surname><given-names>SG</given-names></name></person-group><article-title>Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>41975</fpage><lpage>41984</lpage><pub-id pub-id-type="doi">10.1074/jbc.M407707200</pub-id><?supplied-pmid 15280382?><pub-id pub-id-type="pmid">15280382</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H-SV</given-names></name><name><surname>Pellegrini</surname><given-names>JW</given-names></name><name><surname>Aggarwal</surname><given-names>SK</given-names></name><name><surname>Lei</surname><given-names>SZ</given-names></name><name><surname>Warach</surname><given-names>S</given-names></name></person-group><article-title>Open-channel block of N-methyl-D-aspartat (NMDA) responses by memantine: therapeutic advantage against NMDA-mediated neurotoxicity</article-title><source>J Neurosci</source><year>1992</year><volume>12</volume><fpage>4427</fpage><lpage>4436</lpage><?supplied-pmid 1432103?><pub-id pub-id-type="pmid">1432103</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>HS</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Rayudu</surname><given-names>PV</given-names></name><name><surname>Edgecomb</surname><given-names>P</given-names></name><name><surname>Neill</surname><given-names>JC</given-names></name><name><surname>Segal</surname><given-names>MM</given-names></name><name><surname>Lipton</surname><given-names>SA</given-names></name><name><surname>Jensen</surname><given-names>FE</given-names></name></person-group><article-title>Neuroprotective concentrations of the N-methyl-D-aspartate open channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation</article-title><source>Neuroscience</source><year>1998</year><volume>86</volume><fpage>1121</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1016/S0306-4522(98)00163-8</pub-id><?supplied-pmid 9697119?><pub-id pub-id-type="pmid">9697119</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name></person-group><article-title>Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2-A and 5, leading to activation of MAPK pathway</article-title><source>Int J Biochem Cell Biol</source><year>2009</year><volume>41</volume><fpage>1284</fpage><lpage>1295</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2008.10.029</pub-id><?supplied-pmid 19038359?><pub-id pub-id-type="pmid">19038359</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>YD</given-names></name><name><surname>Al-Khoury</surname><given-names>L</given-names></name><name><surname>Zivin</surname><given-names>JA</given-names></name></person-group><article-title>Neuroprotection for ischemic stroke: two decades of success and failure</article-title><source>NeurotoxRx</source><year>2004</year><volume>1</volume><fpage>36</fpage><lpage>45</lpage></element-citation></ref><ref id="CR27"><mixed-citation publication-type="other">Committee on Fetus &#x00026; Newborn (Papile LA, Baley JE, Benitz W, Cummings J, Carlo WA, Eichenwald E, Kumar P, Pollin RA, Tan RC, Wang KS) (2014) Hypothermia and neonatal encephalopathy. Am Acad Pediatr, 1098&#x02013;1275; doi: 10.1542/peds.%202014-0899</mixed-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunnane</surname><given-names>SC</given-names></name><name><surname>Menard</surname><given-names>CR</given-names></name><name><surname>Likhodii</surname><given-names>SS</given-names></name><name><surname>Brenna</surname><given-names>JT</given-names></name><name><surname>Crawford</surname><given-names>MA</given-names></name></person-group><article-title>Carbon recycling into de novo lipogenesis is a major pathway in neonatal metabolism of linoleate and alpha-linolenate</article-title><source>Prostsg Leukotr Ess</source><year>1999</year><volume>60</volume><fpage>387</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/S0952-3278(99)80018-0</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunnane</surname><given-names>SC</given-names></name><name><surname>Crawford</surname><given-names>MA</given-names></name></person-group><article-title>Energetic and nutritional constraints on infant brain development: implications for brain expansion during human evolution</article-title><source>J Human Evol</source><year>2014</year><volume>77</volume><fpage>88</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.jhevol.2014.05.001</pub-id><pub-id pub-id-type="pmid">24928072</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danbolt</surname><given-names>NC</given-names></name></person-group><article-title>Glutamate uptake</article-title><source>Prog Neurobiol</source><year>2001</year><volume>65</volume><fpage>1</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/S0301-0082(00)00067-8</pub-id><?supplied-pmid 11369436?><pub-id pub-id-type="pmid">11369436</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danysz</surname><given-names>W</given-names></name><name><surname>Parsons</surname><given-names>CG</given-names></name><name><surname>Kornhuber</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>WJ</given-names></name><name><surname>Quack</surname><given-names>G</given-names></name></person-group><article-title>Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents&#x02014;preclinical studies</article-title><source>Neurosci Biobehav Rev</source><year>1997</year><volume>21</volume><fpage>455</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/S0149-7634(96)00037-1</pub-id><?supplied-pmid 9195603?><pub-id pub-id-type="pmid">9195603</pub-id></element-citation></ref><ref id="CR32"><mixed-citation publication-type="other">Davidson JO, Green CR, Bennet L, Gunn AJ (2015) Battle of the hemichannels-Connexins and Pannexins in ischemic brain injury. Int J Develop Neurosci. doi: 10.1016/EP%202014.12.07</mixed-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>W</given-names></name></person-group><article-title>Neurobiology of injury to the developing brain</article-title><source>Nat Rev Neurol</source><year>2010</year><volume>6</volume><fpage>328</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2010.53</pub-id><?supplied-pmid 20479779?><pub-id pub-id-type="pmid">20479779</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas-Escobar</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>MD</given-names></name></person-group><article-title>Hypoxic-ischemic encephalopathy; a review for the clinician</article-title><source>JAMA Pediatr</source><year>2015</year><volume>169</volume><fpage>397</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1001/jamapediatrics.2014.3269</pub-id><?supplied-pmid 25685948?><pub-id pub-id-type="pmid">25685948</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>Y</given-names></name><name><surname>Gross</surname><given-names>RA</given-names></name><name><surname>Sheu</surname><given-names>SS</given-names></name></person-group><article-title>Ca2+-dependent generation of mitochondrial reactive oxygene species serves as a signal for poly(ADP-ribose) polymerase-1 activation during glutamate excitotoxicity</article-title><source>J Physiol</source><year>2007</year><volume>585</volume><fpage>741</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2007.145409</pub-id><?supplied-pmid 17947304?><pub-id pub-id-type="pmid">17947304</pub-id></element-citation></ref><ref id="CR36"><mixed-citation publication-type="other">Edwards AD, Brockhurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, Strohm B, Thoresen M, Withelaw A, Azzopardi D (2010) Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalophaty: synthesis and meta-analysis of trial data. Brit Med J. doi: 10.1136/bmj.c363</mixed-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engidawork</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Dell&#x02019;Anna</surname><given-names>E</given-names></name><name><surname>Goiny</surname><given-names>M</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name><name><surname>Ungerstedt</surname><given-names>U</given-names></name><name><surname>Andersson</surname><given-names>K</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Effects of perinatal asphyxia on systemic and intracerebral glycolysis metabolism and pH in the rat</article-title><source>Exp Neurol</source><year>1997</year><volume>145</volume><fpage>390</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1006/exnr.1997.6482</pub-id><?supplied-pmid 9217075?><pub-id pub-id-type="pmid">9217075</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engidawork</surname><given-names>E</given-names></name><name><surname>Loidl</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Kohlhauser</surname><given-names>C</given-names></name><name><surname>Stoeckler</surname><given-names>S</given-names></name><name><surname>Dell&#x02019;Anna</surname><given-names>E</given-names></name><name><surname>Lubec</surname><given-names>B</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name><name><surname>Goiny</surname><given-names>M</given-names></name><name><surname>Gross</surname><given-names>J</given-names></name><name><surname>Andersson</surname><given-names>K</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia</article-title><source>Exp Brain Res</source><year>2001</year><volume>138</volume><fpage>375</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1007/s002210100710</pub-id><?supplied-pmid 11460776?><pub-id pub-id-type="pmid">11460776</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erecinska</surname><given-names>M</given-names></name><name><surname>Thoresen</surname><given-names>M</given-names></name><name><surname>Silver</surname><given-names>IA</given-names></name></person-group><article-title>Effects of hypothermia on energy metabolism in: mammalian central nervous system</article-title><source>J Cereb Blood Flow Metab</source><year>2003</year><volume>23</volume><fpage>513</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1097/01.WCB.0000066287.21705.21</pub-id><?supplied-pmid 12771566?><pub-id pub-id-type="pmid">12771566</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fellman</surname><given-names>V</given-names></name><name><surname>Raivio</surname><given-names>KO</given-names></name></person-group><article-title>Reperfusion injury as the mechanism of brain damage after perinatal asphyxia</article-title><source>Pediatr Res</source><year>1997</year><volume>41</volume><fpage>599</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1203/00006450-199705000-00001</pub-id><?supplied-pmid 9128279?><pub-id pub-id-type="pmid">9128279</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores-Balter</surname><given-names>G</given-names></name><name><surname>Cordova-Jadue</surname><given-names>H</given-names></name><name><surname>Chiti-Morales</surname><given-names>A</given-names></name><name><surname>Lespay</surname><given-names>C</given-names></name><name><surname>Espina-Marchant</surname><given-names>P</given-names></name><name><surname>Falcon</surname><given-names>R</given-names></name><name><surname>Grinspun</surname><given-names>N</given-names></name><name><surname>Sanchez</surname><given-names>J</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Vald&#x000e9;s</surname><given-names>JL</given-names></name></person-group><article-title>Effect of perinatal asphyxia on tuberomammillary nucleus neuronal density and object recognition memory: a possible role for histamine?</article-title><source>Behav Brain Res</source><year>2016</year><volume>313</volume><fpage>226</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2016.07.026</pub-id><?supplied-pmid 27444242?><pub-id pub-id-type="pmid">27444242</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>DL</given-names></name><name><surname>Roberts</surname><given-names>R</given-names></name></person-group><article-title>Compartmentation of brain-type creatine kinase and ubiquitous mitochondrial creatine kinase in neurons: evidence for a creatine phosphate energy shuttle in adult brain</article-title><source>J Comp Neurol</source><year>1994</year><volume>343</volume><fpage>500</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1002/cne.903430311</pub-id><?supplied-pmid 7517967?><pub-id pub-id-type="pmid">7517967</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galeano</surname><given-names>P</given-names></name><name><surname>Blanco-Calvo</surname><given-names>E</given-names></name><name><surname>Madureira-de Oliveira</surname><given-names>D</given-names></name><name><surname>Cuenya</surname><given-names>L</given-names></name><name><surname>Kamenetzky</surname><given-names>GV</given-names></name><name><surname>Mustaca</surname><given-names>AE</given-names></name><name><surname>Barreto</surname><given-names>GE</given-names></name><name><surname>Giraldez-Alvarez</surname><given-names>LD</given-names></name><name><surname>Milei</surname><given-names>J</given-names></name><name><surname>Capani</surname><given-names>F</given-names></name></person-group><article-title>Long-lasting effects of perinatal asphyxia on exploration, memory and incentive downshift</article-title><source>Int J Dev Neurosci</source><year>2011</year><volume>29</volume><fpage>609</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/j.ijdevneu.2011.05.002</pub-id><?supplied-pmid 21640811?><pub-id pub-id-type="pmid">21640811</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galeano</surname><given-names>P</given-names></name><name><surname>Blanco</surname><given-names>E</given-names></name><name><surname>Logica Tornatore</surname><given-names>TM</given-names></name><name><surname>Romero</surname><given-names>JI</given-names></name><name><surname>Holubiec</surname><given-names>MI</given-names></name><name><surname>Rodr&#x000ed;guez de Fonseca</surname><given-names>F</given-names></name><name><surname>Capani</surname><given-names>F</given-names></name></person-group><article-title>Life-long environmental enrichment counteracts spatial learning, reference and working memory deficits in middle-aged rats subjected to perinatal asphyxia</article-title><source>Front Behav Neurosci</source><year>2015</year><volume>8</volume><fpage>406</fpage><pub-id pub-id-type="doi">10.3389/fnbeh.2014.00406</pub-id><?supplied-pmid 25601829?><pub-id pub-id-type="pmid">25601829</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Munoz</surname><given-names>M</given-names></name><name><surname>Lopez-Huerta</surname><given-names>V</given-names></name><name><surname>Carrillo-Reid</surname><given-names>L</given-names></name><name><surname>Arbuthnott</surname><given-names>G</given-names></name></person-group><article-title>Extrasynaptic glutamate NMDA receptors: key players in striatal function</article-title><source>Neuropharmacology</source><year>2015</year><volume>89</volume><fpage>54</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.09.013</pub-id><?supplied-pmid 25239809?><pub-id pub-id-type="pmid">25239809</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gahwiler</surname><given-names>BH</given-names></name></person-group><article-title>Organotypic monolayer cultures of the nervous tissue</article-title><source>J Neurosci Methods</source><year>1981</year><volume>4</volume><fpage>329</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1016/0165-0270(81)90003-0</pub-id><?supplied-pmid 7033675?><pub-id pub-id-type="pmid">7033675</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glasow</surname><given-names>NC</given-names></name><name><surname>Retchless</surname><given-names>B</given-names></name><name><surname>Johnson</surname><given-names>JW</given-names></name></person-group><article-title>Molecular bases of NMDA receptor subtype-dependent properties</article-title><source>J Physiol</source><year>2015</year><volume>593</volume><fpage>83</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2014.273763</pub-id><pub-id pub-id-type="pmid">25556790</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Urquijo</surname><given-names>S</given-names></name><name><surname>Hokfelt</surname><given-names>T</given-names></name><name><surname>Ubink</surname><given-names>R</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Neurocircuitries of the basal ganglia studied in organotypic cultures: focus on tyrosine hydroxylase, nitric oxide synthase and neuropetide immunocytochemistry</article-title><source>Neuroscience</source><year>1999</year><volume>94</volume><fpage>1133</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1016/S0306-4522(99)00415-7</pub-id><?supplied-pmid 10625053?><pub-id pub-id-type="pmid">10625053</pub-id></element-citation></ref><ref id="CR49"><mixed-citation publication-type="other">Gonzalez-Flores A, Aguilar-Quesada R, Siles E, Pozo S, Rodriguez-Lara MI, Lopez-Jimenez L, Lopez-Rodriguez M, Peralta-Leal A, Villar D, Martin-Oliva D del Peso L, Berra E, Oliver FJ (2014) Interaction between PARP-1 and HIF-2alpha in the hypoxic response. Oncogene 33:891&#x02013;898.</mixed-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groc</surname><given-names>L</given-names></name><name><surname>Bard</surname><given-names>L</given-names></name><name><surname>Choquet</surname><given-names>D</given-names></name></person-group><article-title>Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives</article-title><source>Neuroscience</source><year>2009</year><volume>158</volume><fpage>4</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.05.029</pub-id><?supplied-pmid 18583064?><pub-id pub-id-type="pmid">18583064</pub-id></element-citation></ref><ref id="CR51"><mixed-citation publication-type="other">Gunn AJ, Thoresen M (2015) Animal studies of neonatal hypothermic neuroprotection have translated well in to practice. J Resuscitation. doi: 10.1016/j.resuscitation.2015.03.026</mixed-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>H</given-names></name><name><surname>Edwards</surname><given-names>AD</given-names></name><name><surname>Groenendaal</surname><given-names>F</given-names></name></person-group><article-title>Perinatal brain damage: the term infant</article-title><source>Neurobiol Dis</source><year>2016</year><volume>92</volume><fpage>102</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2015.09.011</pub-id><?supplied-pmid 26409031?><pub-id pub-id-type="pmid">26409031</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanschmann</surname><given-names>E-M</given-names></name><name><surname>Godoy</surname><given-names>JR</given-names></name><name><surname>Berndt</surname><given-names>C</given-names></name><name><surname>Hudemann</surname><given-names>C</given-names></name><name><surname>Lillig</surname><given-names>CH</given-names></name></person-group><article-title>Thioredoxins, glutaterodoxins, and peroxiredoxins&#x02014;molecular mechanisms and health. Significance: from cofactors to antioxidants to redox signalling</article-title><source>Antioxid Redox Signal</source><year>2013</year><volume>19</volume><fpage>1539</fpage><lpage>1605</lpage><pub-id pub-id-type="doi">10.1089/ars.2012.4599</pub-id><?supplied-pmid 23397885?><pub-id pub-id-type="pmid">23397885</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardingham</surname><given-names>GE</given-names></name><name><surname>Bading</surname><given-names>H</given-names></name></person-group><article-title>Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders</article-title><source>Nat Rev Neurosci</source><year>2010</year><volume>11</volume><fpage>682</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1038/nrn2911</pub-id><?supplied-pmid 20842175?><pub-id pub-id-type="pmid">20842175</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>F</given-names></name><name><surname>Murayama</surname><given-names>N</given-names></name><name><surname>Noshita</surname><given-names>T</given-names></name><name><surname>Oikawa</surname><given-names>S</given-names></name></person-group><article-title>Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitototxic injury in vivo</article-title><source>J Neurochem</source><year>2003</year><volume>86</volume><fpage>860</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.01918.x</pub-id><?supplied-pmid 12887684?><pub-id pub-id-type="pmid">12887684</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Loidl</surname><given-names>CF</given-names></name><name><surname>Andersson</surname><given-names>K</given-names></name><name><surname>Ungerstedt</surname><given-names>U</given-names></name></person-group><article-title>Prevention of mortality induced by perinatal asphyxia: hypothermia or glutamate anstagonism?</article-title><source>Amino Acids</source><year>1993</year><volume>5</volume><fpage>413</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1007/BF00806959</pub-id><?supplied-pmid 24190712?><pub-id pub-id-type="pmid">24190712</pub-id></element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Loidl</surname><given-names>CF</given-names></name><name><surname>You</surname><given-names>Z-B</given-names></name><name><surname>Andersson</surname><given-names>K</given-names></name><name><surname>Silveira</surname><given-names>R</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>WT</given-names></name><name><surname>Goiny</surname><given-names>M</given-names></name></person-group><article-title>Neurocircuitry of the basal ganglia studied by monitoring neurotransmitter release. Effects of intracerebral and perinatal asphyctic lesions</article-title><source>Mol Neurobiol</source><year>1994</year><volume>9</volume><fpage>171</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1007/BF02816117</pub-id><?supplied-pmid 7888094?><pub-id pub-id-type="pmid">7888094</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Goiny</surname><given-names>M</given-names></name><name><surname>Meana</surname><given-names>JJ</given-names></name><name><surname>Silveira</surname><given-names>R</given-names></name><name><surname>Godukhin</surname><given-names>O</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Espinoza</surname><given-names>S</given-names></name><name><surname>Pettersson</surname><given-names>E</given-names></name><name><surname>Loidl</surname><given-names>F</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name><name><surname>Andersson</surname><given-names>K</given-names></name><name><surname>Nylander</surname><given-names>I</given-names></name><name><surname>Terenius</surname><given-names>L</given-names></name><name><surname>Ungerstedt</surname><given-names>U</given-names></name></person-group><article-title>On the origin of extracellular glutamate levels monitored in the basal ganglia by in vivo microdialysis</article-title><source>J Neurochem</source><year>1996</year><volume>66</volume><fpage>1726</fpage><lpage>1735</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.1996.66041726.x</pub-id><?supplied-pmid 8627331?><pub-id pub-id-type="pmid">8627331</pub-id></element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>WJ</given-names></name></person-group><article-title>Amino acids in neurobiology (eds)</article-title><source>Amino Acids</source><year>2000</year><volume>19</volume><fpage>1</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1007/s007260070031</pub-id></element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Goiny</surname><given-names>M</given-names></name></person-group><article-title>Exploring neurocircuitries of the basal ganglia by intracerebral administration of selective neurotoxins</article-title><source>Neurotox Res</source><year>2007</year><volume>11</volume><fpage>169</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1007/BF03033566</pub-id><?supplied-pmid 17449458?><pub-id pub-id-type="pmid">17449458</pub-id></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Arbuthnott</surname><given-names>G</given-names></name><name><surname>Ungerstedt</surname><given-names>U</given-names></name></person-group><article-title>The rotational model and microdialysis: significance for dopamine signalling, clinical studies and beyond</article-title><source>Prog Neurobiol</source><year>2010</year><volume>90</volume><fpage>176</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2009.01.005</pub-id><?supplied-pmid 20185033?><pub-id pub-id-type="pmid">20185033</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Leyton</surname><given-names>L</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Klawitter</surname><given-names>V</given-names></name><name><surname>Espina-Marchant</surname><given-names>P</given-names></name><name><surname>Allende</surname><given-names>C</given-names></name><name><surname>Lisboa</surname><given-names>F</given-names></name><name><surname>Cunich</surname><given-names>G</given-names></name><name><surname>Jara-Cavieres</surname><given-names>A</given-names></name><name><surname>Neira</surname><given-names>T</given-names></name><name><surname>Gutierrez-Hernandez</surname><given-names>MA</given-names></name><name><surname>Gonzalez-Lira</surname><given-names>V</given-names></name><name><surname>Simola</surname><given-names>N</given-names></name><name><surname>Schmitt</surname><given-names>A</given-names></name><name><surname>Morelli</surname><given-names>M</given-names></name><name><surname>Andrew Tasker</surname><given-names>R</given-names></name><name><surname>Gebicke-Haerter</surname><given-names>PJ</given-names></name></person-group><article-title>Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins</article-title><source>Neurotox Res</source><year>2011</year><volume>19</volume><fpage>603</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1007/s12640-010-9208-9</pub-id><?supplied-pmid 20645042?><pub-id pub-id-type="pmid">20645042</pub-id></element-citation></ref><ref id="CR63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Neira-Pena</surname><given-names>T</given-names></name><name><surname>Rojas-Mancilla</surname><given-names>E</given-names></name><name><surname>Espina-Marchant</surname><given-names>P</given-names></name><name><surname>Esmar</surname><given-names>D</given-names></name><name><surname>Perez</surname><given-names>R</given-names></name><name><surname>Munoz</surname><given-names>V</given-names></name><name><surname>Gutierrez-Hernandez</surname><given-names>MA</given-names></name><name><surname>Rivera</surname><given-names>B</given-names></name><name><surname>Simola</surname><given-names>N</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Gebicke-Haerter</surname><given-names>PJ</given-names></name></person-group><article-title>Perinatal asphyxia: CNS development and deficits with delayed onset</article-title><source>Front Neurosci</source><year>2014</year><volume>8</volume><fpage>1</fpage><lpage>1</lpage><pub-id pub-id-type="doi">10.3389/fnins.2014.00047</pub-id><pub-id pub-id-type="pmid">24478622</pub-id></element-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>SJ</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name><name><surname>Dawson</surname><given-names>VL</given-names></name></person-group><article-title>Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signalling</article-title><source>Trends in Pharmacol Sci</source><year>2004</year><volume>25</volume><fpage>259</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2004.03.005</pub-id><pub-id pub-id-type="pmid">15120492</pub-id></element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>J-J</given-names></name><name><surname>Choi</surname><given-names>S-Y</given-names></name><name><surname>Koh</surname><given-names>J-Y</given-names></name></person-group><article-title>The role of NADPH oxidase, neuronal nitric oxide synthase and poly(ADP ribose) polymerase in oxidative neuronal death induced in cortical cultures by brain-derived neurotrophic factor and neurotrophin-4/5</article-title><source>J Neurochem</source><year>2002</year><volume>82</volume><fpage>894</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2002.01040.x</pub-id><?supplied-pmid 12358795?><pub-id pub-id-type="pmid">12358795</pub-id></element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikonomidou</surname><given-names>C</given-names></name><name><surname>Bosch</surname><given-names>F</given-names></name><name><surname>Miksa</surname><given-names>M</given-names></name><name><surname>Bittigau</surname><given-names>P</given-names></name><name><surname>Vockler</surname><given-names>J</given-names></name><name><surname>Dikranian</surname><given-names>K</given-names></name><name><surname>Tenkova</surname><given-names>TI</given-names></name><name><surname>Stefovska</surname><given-names>V</given-names></name><name><surname>Turski</surname><given-names>L</given-names></name><name><surname>Olney</surname><given-names>JW</given-names></name></person-group><article-title>Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain</article-title><source>Science</source><year>1999</year><volume>283</volume><fpage>70</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1126/science.283.5398.70</pub-id><?supplied-pmid 9872743?><pub-id pub-id-type="pmid">9872743</pub-id></element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ireland</surname><given-names>Z</given-names></name><name><surname>Dickinson</surname><given-names>H</given-names></name><name><surname>Snow</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>DW</given-names></name></person-group><article-title>Maternal creatine: does it reach the fetus and improve survival after an acute hypoxic episode in the spiny mouse (Acomys caharinus)?</article-title><source>Am J Obstet Gynecol</source><year>2008</year><volume>198</volume><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2007.10.790</pub-id><?supplied-pmid 18295173?><pub-id pub-id-type="pmid">18295173</pub-id></element-citation></ref><ref id="CR68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ireland</surname><given-names>Z</given-names></name><name><surname>Castillo-Melendez</surname><given-names>M</given-names></name><name><surname>Dickison</surname><given-names>H</given-names></name><name><surname>Snow</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>DW</given-names></name></person-group><article-title>A maternal diet supplemented with creatine from mid-pregnancy protecs the nwborn spiny mousee brain from birth hypoxia</article-title><source>Neuroscience</source><year>2011</year><volume>194</volume><fpage>372</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.05.012</pub-id><?supplied-pmid 21640166?><pub-id pub-id-type="pmid">21640166</pub-id></element-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Israel</surname><given-names>Y</given-names></name><name><surname>Karahanian</surname><given-names>E</given-names></name><name><surname>Ezquer</surname><given-names>F</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Ezquer</surname><given-names>M</given-names></name><name><surname>Rivera-Meza</surname><given-names>M</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Quintanilla</surname><given-names>ME</given-names></name></person-group><article-title>Acquisition, maintenance and relapse-like alcohol drinking: lessons from the UChB rat line</article-title><source>Front Behav Neurosci</source><year>2017</year><volume>11</volume><fpage>57</fpage><pub-id pub-id-type="doi">10.3389/fnbeh.2017.00057</pub-id><?supplied-pmid 28420969?><pub-id pub-id-type="pmid">28420969</pub-id></element-citation></ref><ref id="CR70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobucci</surname><given-names>GJ</given-names></name><name><surname>Popescu</surname><given-names>GK</given-names></name></person-group><article-title>NMDA receptors: linking physiological output to biophysical operation</article-title><source>Nature Rev</source><year>2017</year><volume>18</volume><fpage>236</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1038/nrn.2017.24</pub-id></element-citation></ref><ref id="CR71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>SV</given-names></name><name><surname>Mathur</surname><given-names>A</given-names></name><name><surname>Srinivasakumar</surname><given-names>P</given-names></name><name><surname>Wallendorf</surname><given-names>M</given-names></name><name><surname>Culver</surname><given-names>JP</given-names></name><name><surname>Zempel</surname><given-names>JM</given-names></name></person-group><article-title>Prediction of neonatal seizures in hypoxic-ischemic encephalopathy using electroencephalograph power analyses</article-title><source>Pediatr Neurol</source><year>2017</year><volume>67</volume><fpage>64</fpage><lpage>70.e2</lpage><pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2016.10.019</pub-id><?supplied-pmid 28062149?><pub-id pub-id-type="pmid">28062149</pub-id></element-citation></ref><ref id="CR72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>LL</given-names></name><name><surname>Talos</surname><given-names>DM</given-names></name><name><surname>Jackson</surname><given-names>MC</given-names></name><name><surname>Park</surname><given-names>H-K</given-names></name><name><surname>Graham</surname><given-names>DA</given-names></name><name><surname>Lechpammer</surname><given-names>M</given-names></name><name><surname>Folkern</surname><given-names>RD</given-names></name><name><surname>Volpe</surname><given-names>JJ</given-names></name><name><surname>Jensen</surname><given-names>FE</given-names></name></person-group><article-title>Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain</article-title><source>Cereb Cortex</source><year>2015</year><volume>25</volume><fpage>482</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1093/cercor/bht246</pub-id><?supplied-pmid 24046081?><pub-id pub-id-type="pmid">24046081</pub-id></element-citation></ref><ref id="CR73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JW</given-names></name><name><surname>Glasgow</surname><given-names>NG</given-names></name><name><surname>Polysheva</surname><given-names>NV</given-names></name></person-group><article-title>Recent insights into the mode of action of memantine and ketamine</article-title><source>Curr Opinion Pharmacol</source><year>2015</year><volume>20</volume><fpage>54</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2014.11.006</pub-id></element-citation></ref><ref id="CR74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kavirajan</surname><given-names>H</given-names></name></person-group><article-title>Memantine a comprensive review of safety and efficacy</article-title><source>Expert Opinion Drug Saf</source><year>2009</year><volume>8</volume><fpage>89</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1517/14740330802528420</pub-id></element-citation></ref><ref id="CR75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamura</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>N</given-names></name><name><surname>Shibata</surname><given-names>K</given-names></name></person-group><article-title>&#x003b2;-Nicotinamide mononucleotide, an anti-aging cadidate compoun, is retained in the body for longer than nicotinamide in ratas</article-title><source>J Nutr Sci Vitaminol (Tokyo)</source><year>2016</year><volume>62</volume><fpage>272</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.3177/jnsv.62.272</pub-id><pub-id pub-id-type="pmid">27725413</pub-id></element-citation></ref><ref id="CR76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ke</surname><given-names>Q</given-names></name><name><surname>Costa</surname><given-names>M</given-names></name></person-group><article-title>Hypoxia-inducible factor-1 (HIF-1)</article-title><source>Mol Pharmacol</source><year>2006</year><volume>70</volume><fpage>1469</fpage><lpage>14680</lpage><pub-id pub-id-type="doi">10.1124/mol.106.027029</pub-id><?supplied-pmid 16887934?><pub-id pub-id-type="pmid">16887934</pub-id></element-citation></ref><ref id="CR77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klawitter</surname><given-names>V</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Goiny</surname><given-names>M</given-names></name><name><surname>Gross</surname><given-names>J</given-names></name><name><surname>Luthman</surname><given-names>J</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Effect of perinatal asphyxia on cell survival, neuronal phenotype and neurite growth evaluated with organotypic triple cultures</article-title><source>Amino Acids</source><year>2005</year><volume>28</volume><fpage>149</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1007/s00726-005-0161-5</pub-id><?supplied-pmid 15723243?><pub-id pub-id-type="pmid">15723243</pub-id></element-citation></ref><ref id="CR78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klawitter</surname><given-names>V</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Gomez-Urquijo</surname><given-names>S</given-names></name><name><surname>H&#x000f6;kfelt</surname><given-names>T</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Plasticity of basal ganglia neurocircuitries following perinatal asphyxia: neuroprotection by nicotinamide</article-title><source>Exp Brain Res</source><year>2007</year><volume>180</volume><fpage>139</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1007/s00221-006-0842-7</pub-id><?supplied-pmid 17310378?><pub-id pub-id-type="pmid">17310378</pub-id></element-citation></ref><ref id="CR79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohlhauser</surname><given-names>C</given-names></name><name><surname>Mosgoeller</surname><given-names>W</given-names></name><name><surname>Hoeger</surname><given-names>H</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name><name><surname>Lubec</surname><given-names>B</given-names></name></person-group><article-title>Cholinergic, monoaminergic and glutamatergic changes following perinatal asphyxia in the rat</article-title><source>Cell Mol Life Sci</source><year>1999</year><volume>55</volume><fpage>491</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1007/s000180050388</pub-id></element-citation></ref><ref id="CR80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohlhauser</surname><given-names>C</given-names></name><name><surname>Kaehler</surname><given-names>S</given-names></name><name><surname>Mosgoeller</surname><given-names>W</given-names></name><name><surname>Singewald</surname><given-names>N</given-names></name><name><surname>Koulevas</surname><given-names>D</given-names></name><name><surname>Prast</surname><given-names>H</given-names></name><name><surname>Hoeger</surname><given-names>H</given-names></name><name><surname>Lubec</surname><given-names>B</given-names></name></person-group><article-title>Histological changes and neurotransmitter levels three months following perinatal asphyxia in the rat</article-title><source>Life Sci</source><year>1999</year><volume>64</volume><fpage>2109</fpage><lpage>2124</lpage><pub-id pub-id-type="doi">10.1016/S0024-3205(99)00160-5</pub-id><?supplied-pmid 10372653?><pub-id pub-id-type="pmid">10372653</pub-id></element-citation></ref><ref id="CR81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krantic</surname><given-names>S</given-names></name><name><surname>Mechawar</surname><given-names>N</given-names></name><name><surname>Reix</surname><given-names>S</given-names></name><name><surname>Quirion</surname><given-names>R</given-names></name></person-group><article-title>Apoptosis&#x02013;inducing factor: a matter of neuron life and death</article-title><source>Prog Neurobiol</source><year>2007</year><volume>81</volume><fpage>179</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2006.12.002</pub-id><?supplied-pmid 17267093?><pub-id pub-id-type="pmid">17267093</pub-id></element-citation></ref><ref id="CR82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krieglstein</surname><given-names>J</given-names></name><name><surname>Seif el Nasr</surname><given-names>M</given-names></name><name><surname>Lipper</surname><given-names>K</given-names></name></person-group><article-title>Neuroprotection by memantine as increased by hypothermia and nimodipine</article-title><source>Eur J Pharm Sci</source><year>1997</year><volume>5</volume><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/S0928-0987(96)00257-6</pub-id></element-citation></ref><ref id="CR83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurinczuk</surname><given-names>JJ</given-names></name><name><surname>White-Konig</surname><given-names>M</given-names></name><name><surname>Badawi</surname><given-names>N</given-names></name></person-group><article-title>Epidemiology of neonatal encephalopathy and hypoxic-ischemic encephalopathy</article-title><source>Early Hum Dev</source><year>2010</year><volume>86</volume><fpage>329</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.earlhumdev.2010.05.010</pub-id><?supplied-pmid 20554402?><pub-id pub-id-type="pmid">20554402</pub-id></element-citation></ref><ref id="CR84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafemina</surname><given-names>MJ</given-names></name><name><surname>Sheldon</surname><given-names>RA</given-names></name><name><surname>Ferreiro</surname><given-names>DM</given-names></name></person-group><article-title>Acute hypoxia-ischemia results in hydrogen proxide accumulation in neonatal but not adult mouse brain</article-title><source>Pediatric Res</source><year>2006</year><volume>59</volume><fpage>680</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1203/01.pdr.0000214891.35363.6a</pub-id></element-citation></ref><ref id="CR85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laptook</surname><given-names>AR</given-names></name><name><surname>Cirbett</surname><given-names>RJ</given-names></name><name><surname>Sterett</surname><given-names>R</given-names></name><name><surname>Garcia</surname><given-names>D</given-names></name><name><surname>Tollfsbol</surname><given-names>G</given-names></name></person-group><article-title>Quantitative relationship between brain temperature and energy utilization measured in vivo using 31P and 1H magnetic resonance spectroscopy</article-title><source>Pediatr Res</source><year>1995</year><volume>38</volume><fpage>919</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1203/00006450-199512000-00015</pub-id><?supplied-pmid 8618794?><pub-id pub-id-type="pmid">8618794</pub-id></element-citation></ref><ref id="CR86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>SA</given-names></name></person-group><article-title>Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond</article-title><source>Nat Rev Drug Discov</source><year>2006</year><volume>5</volume><fpage>160</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1038/nrd1958</pub-id><?supplied-pmid 16424917?><pub-id pub-id-type="pmid">16424917</pub-id></element-citation></ref><ref id="CR87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loftis</surname><given-names>JM</given-names></name><name><surname>Janosky</surname><given-names>A</given-names></name></person-group><article-title>The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation and clinical implications</article-title><source>Pharmacol Ther</source><year>2003</year><volume>97</volume><fpage>55</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/S0163-7258(02)00302-9</pub-id><?supplied-pmid 12493535?><pub-id pub-id-type="pmid">12493535</pub-id></element-citation></ref><ref id="CR88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lourenco dos Santos</surname><given-names>S</given-names></name><name><surname>Baraibar</surname><given-names>MA</given-names></name><name><surname>Lundberg</surname><given-names>S</given-names></name><name><surname>Eeg-Olofsson</surname><given-names>O</given-names></name><name><surname>Larsson</surname><given-names>L</given-names></name><name><surname>Friguet</surname><given-names>B</given-names></name></person-group><article-title>Oxidative proteome alterations during skeletal muscle aging</article-title><source>Redox Biol</source><year>2015</year><volume>5</volume><fpage>267</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2015.05.006</pub-id><?supplied-pmid 26073261?><pub-id pub-id-type="pmid">26073261</pub-id></element-citation></ref><ref id="CR89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Low</surname><given-names>JA</given-names></name></person-group><article-title>Determining the contribution of asphyxia to brain damage in the neonate</article-title><source>J Obstet Gynaecol Res</source><year>2004</year><volume>30</volume><fpage>276</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1111/j.1447-0756.2004.00194.x</pub-id><?supplied-pmid 15238103?><pub-id pub-id-type="pmid">15238103</pub-id></element-citation></ref><ref id="CR90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubec</surname><given-names>B</given-names></name><name><surname>Marx</surname><given-names>M</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Labudova</surname><given-names>O</given-names></name><name><surname>Hoeger</surname><given-names>H</given-names></name><name><surname>Gille</surname><given-names>L</given-names></name><name><surname>Nohl</surname><given-names>H</given-names></name><name><surname>Mosgoeller</surname><given-names>W</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name></person-group><article-title>Decrease of heart protein kinase C and cyclin-dependent kinase precedes death in perinatal asphyxia of the rat</article-title><source>FASEB J</source><year>1997</year><volume>11</volume><fpage>482</fpage><lpage>492</lpage><?supplied-pmid 9194529?><pub-id pub-id-type="pmid">9194529</pub-id></element-citation></ref><ref id="CR91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubec</surname><given-names>B</given-names></name><name><surname>Dell&#x02019;Anna</surname><given-names>E</given-names></name><name><surname>Fang-Kircher</surname><given-names>S</given-names></name><name><surname>Marx</surname><given-names>M</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name></person-group><article-title>Decrease of brain protein kinase C, protein kinase A, and cyclin-dependent kinase correlating with pH precedes neuronal death in neonatal asphyxia</article-title><source>J Investig Med</source><year>1997</year><volume>45</volume><fpage>284</fpage><lpage>294</lpage><?supplied-pmid 9250002?><pub-id pub-id-type="pmid">9250002</pub-id></element-citation></ref><ref id="CR92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubec</surname><given-names>B</given-names></name><name><surname>Chiappe-Gutierrez</surname><given-names>M</given-names></name><name><surname>Hoeger</surname><given-names>H</given-names></name><name><surname>Kitzmueller</surname><given-names>E</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name></person-group><article-title>Glucose transporters, hexokinases and phosphofructokinase in brain of rats with perinatal asphyxia</article-title><source>Pediatric Res</source><year>2000</year><volume>47</volume><fpage>84</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1203/00006450-200001000-00016</pub-id></element-citation></ref><ref id="CR93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makarewicz</surname><given-names>D</given-names></name><name><surname>Sulejczak</surname><given-names>D</given-names></name><name><surname>Duszczyk</surname><given-names>M</given-names></name><name><surname>Malek</surname><given-names>M</given-names></name><name><surname>Slomka</surname><given-names>M</given-names></name><name><surname>Lazarewicz</surname><given-names>JW</given-names></name></person-group><article-title>Delayed preconditioning with NMDA receptor antagonist in a rat model of perinatal asphyxia</article-title><source>Folia Neuropathol</source><year>2014</year><volume>52</volume><fpage>270</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.5114/fn.2014.45568</pub-id><?supplied-pmid 25310738?><pub-id pub-id-type="pmid">25310738</pub-id></element-citation></ref><ref id="CR94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manning</surname><given-names>SM</given-names></name><name><surname>Griffin</surname><given-names>B</given-names></name><name><surname>Fitzgerald</surname><given-names>E</given-names></name><name><surname>Selip</surname><given-names>DB</given-names></name><name><surname>Volpe</surname><given-names>JJ</given-names></name><name><surname>Jensen</surname><given-names>FE</given-names></name></person-group><article-title>The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain</article-title><source>Int J Dev Neurosci</source><year>2011</year><volume>29</volume><fpage>767</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.1016/j.ijdevneu.2011.05.005</pub-id><?supplied-pmid 21624454?><pub-id pub-id-type="pmid">21624454</pub-id></element-citation></ref><ref id="CR95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marriott</surname><given-names>AL</given-names></name><name><surname>Rojas-Mancilla</surname><given-names>E</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Tasker</surname><given-names>RA</given-names></name></person-group><article-title>Models of progressive neurological dysfunction originating early in life</article-title><source>Prog Neurobiol</source><year>2017</year><volume>155</volume><fpage>2</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.10.001</pub-id><?supplied-pmid 26483068?><pub-id pub-id-type="pmid">26483068</pub-id></element-citation></ref><ref id="CR96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Oliva</surname><given-names>D</given-names></name><name><surname>Aguilar-Quezada</surname><given-names>R</given-names></name><name><surname>Ovalle</surname><given-names>F</given-names></name><name><surname>Mu&#x000f1;oz-Gamez</surname><given-names>JA</given-names></name><name><surname>Martinez-Romero</surname><given-names>R</given-names></name><name><surname>Garc&#x000ed;a del Moral</surname><given-names>R</given-names></name><name><surname>Ruiz de Almodovar</surname><given-names>JM</given-names></name><name><surname>Villuendas</surname><given-names>R</given-names></name><name><surname>Piris</surname><given-names>MA</given-names></name><name><surname>Oliver</surname><given-names>FJ</given-names></name></person-group><article-title>Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia inducible factor-1 activation during skin carcinogenesis</article-title><source>Cancer Res</source><year>2006</year><volume>66</volume><fpage>5744</fpage><lpage>5766</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-3050</pub-id><?supplied-pmid 16740713?><pub-id pub-id-type="pmid">16740713</pub-id></element-citation></ref><ref id="CR97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Romero</surname><given-names>R</given-names></name><name><surname>Canuelo</surname><given-names>A</given-names></name><name><surname>Martinez-Lara</surname><given-names>E</given-names></name><name><surname>Oliver</surname><given-names>J</given-names></name><name><surname>Cardenas</surname><given-names>S</given-names></name><name><surname>Siles</surname><given-names>E</given-names></name></person-group><article-title>Poly(ADP-ribose) polymerase-1 modulation of in vivo response of brain hypoxia-inducible factor-1 to hypoxia/reoxygenation is mediated by nitric oxide and factor inhibiting HIF</article-title><source>J Neurochem</source><year>2009</year><volume>111</volume><fpage>7821</fpage><lpage>7828</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06307.x</pub-id></element-citation></ref><ref id="CR98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massey</surname><given-names>PV</given-names></name><name><surname>Johnson</surname><given-names>BE</given-names></name><name><surname>Moult</surname><given-names>PR</given-names></name><name><surname>Auberson</surname><given-names>YP</given-names></name><name><surname>Brown</surname><given-names>MW</given-names></name><name><surname>Molnar</surname><given-names>E</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name><name><surname>Bashir</surname><given-names>ZI</given-names></name></person-group><article-title>Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-tem potentiation and long-term depression</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>7821</fpage><lpage>7828</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1697-04.2004</pub-id><?supplied-pmid 15356193?><pub-id pub-id-type="pmid">15356193</pub-id></element-citation></ref><ref id="CR99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattson</surname><given-names>M</given-names></name></person-group><article-title>Mitochondrial regulation of neuronal plasticity</article-title><source>Neurochem Res</source><year>2007</year><volume>32</volume><fpage>707</fpage><lpage>715</lpage><pub-id pub-id-type="doi">10.1007/s11064-006-9170-3</pub-id><?supplied-pmid 17024568?><pub-id pub-id-type="pmid">17024568</pub-id></element-citation></ref><ref id="CR100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>KF</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Stein</surname><given-names>LR</given-names></name><name><surname>Grozio</surname><given-names>A</given-names></name><name><surname>Kubota</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Redpath</surname><given-names>P</given-names></name><name><surname>Migaud</surname><given-names>ME</given-names></name><name><surname>Apte</surname><given-names>RS</given-names></name><name><surname>Uchid</surname><given-names>K</given-names></name><name><surname>Yoshino</surname><given-names>J</given-names></name><name><surname>Imai</surname><given-names>SI</given-names></name></person-group><article-title>Long-term dministration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice</article-title><source>Cell Metab</source><year>2016</year><volume>24</volume><fpage>795</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.013</pub-id><?supplied-pmid 28068222?><pub-id pub-id-type="pmid">28068222</pub-id></element-citation></ref><ref id="CR101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moncada</surname><given-names>S</given-names></name><name><surname>Bola&#x000f1;os</surname><given-names>JP</given-names></name></person-group><article-title>Nitric oxide, cell bioenergetics and neurodegeneration</article-title><source>J Neurochem</source><year>2006</year><volume>97</volume><issue>6</issue><fpage>1676</fpage><lpage>1689</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.03988.x</pub-id><?supplied-pmid 16805776?><pub-id pub-id-type="pmid">16805776</pub-id></element-citation></ref><ref id="CR102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Klawitter</surname><given-names>V</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name><name><surname>Huaiqu&#x000ed;n</surname><given-names>P</given-names></name><name><surname>Barros</surname><given-names>VG</given-names></name><name><surname>Avalos</surname><given-names>AM</given-names></name><name><surname>Fiedler</surname><given-names>J</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Gomez-Urquijo</surname><given-names>S</given-names></name><name><surname>Goiny</surname><given-names>M</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Perinatal asphyxia impairs connectivity and dopamine neurite branching in organotypic triple culture from rat substantia nigra, neostriatum and neocortex</article-title><source>Neurosci Lett</source><year>2003</year><volume>348</volume><fpage>175</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/S0304-3940(03)00507-X</pub-id><?supplied-pmid 12932822?><pub-id pub-id-type="pmid">12932822</pub-id></element-citation></ref><ref id="CR103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Fiedler</surname><given-names>JL</given-names></name><name><surname>Andres</surname><given-names>S</given-names></name><name><surname>Berrios</surname><given-names>C</given-names></name><name><surname>Huaiquin</surname><given-names>P</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Cardenas</surname><given-names>S</given-names></name><name><surname>Parra</surname><given-names>E</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Plasticity of hippocampus following perinatal asphyxia: effects on postnatal apoptosis and neurogenesis</article-title><source>J Neurosci Res</source><year>2008</year><volume>86</volume><fpage>2650</fpage><lpage>2662</lpage><pub-id pub-id-type="doi">10.1002/jnr.21715</pub-id><?supplied-pmid 18512760?><pub-id pub-id-type="pmid">18512760</pub-id></element-citation></ref><ref id="CR104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Simola</surname><given-names>N</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Lisboa</surname><given-names>F</given-names></name><name><surname>Fiedler</surname><given-names>J</given-names></name><name><surname>Gebicke-Haerter</surname><given-names>P</given-names></name><name><surname>Morelli</surname><given-names>M</given-names></name><name><surname>Tasker</surname><given-names>RA</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Nicotinamide prevents the long-term effect of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats</article-title><source>Exp Brain Res</source><year>2010</year><volume>202</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1007/s00221-009-2103-z</pub-id><?supplied-pmid 20012537?><pub-id pub-id-type="pmid">20012537</pub-id></element-citation></ref><ref id="CR105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Lipton</surname><given-names>SA</given-names></name></person-group><article-title>Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondria dynamics and neuronal synaptic damage in neurodegenerative diseases</article-title><source>Cell Death Differ</source><year>2011</year><volume>18</volume><fpage>1478</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.65</pub-id><?supplied-pmid 21597461?><pub-id pub-id-type="pmid">21597461</pub-id></element-citation></ref><ref id="CR106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Lipton</surname><given-names>SA</given-names></name></person-group><article-title>Protein S-nitrosylation as a therapeutic target for neurodegenerative diseases</article-title><source>Trends Pharmacol Sci</source><year>2016</year><volume>37</volume><fpage>73</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2015.10.002</pub-id><?supplied-pmid 26707925?><pub-id pub-id-type="pmid">26707925</pub-id></element-citation></ref><ref id="CR107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakashima</surname><given-names>K</given-names></name><name><surname>Todd</surname><given-names>MM</given-names></name></person-group><article-title>Effects of hypothermia on the rate of excitatory amino acid release after ischemic depolarization</article-title><source>Stroke</source><year>1996</year><volume>27</volume><fpage>913</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1161/01.STR.27.5.913</pub-id><?supplied-pmid 8623113?><pub-id pub-id-type="pmid">8623113</pub-id></element-citation></ref><ref id="CR108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neira-Pe&#x000f1;a</surname><given-names>T</given-names></name><name><surname>Rojas-Mancilla</surname><given-names>E</given-names></name><name><surname>Munoz-Vio</surname><given-names>V</given-names></name><name><surname>Perez</surname><given-names>R</given-names></name><name><surname>Gutierrez-Hernandez</surname><given-names>M</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Hermoso</surname><given-names>MA</given-names></name><name><surname>Gebicke-Haerter</surname><given-names>P</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Perinatal asphyxia leads to PARP-1 overactivity, p65 translocation, IL-1&#x003b2; and TNF-&#x003b1; overexpression, and apoptotic-like cell death in mesencephalon of neonatal rats: prevention by systemic neonatal nicotinamide administration</article-title><source>Neurotox Res</source><year>2015</year><volume>27</volume><issue>4</issue><fpage>453</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1007/s12640-015-9517-0</pub-id><?supplied-pmid 25835215?><pub-id pub-id-type="pmid">25835215</pub-id></element-citation></ref><ref id="CR109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nehlig</surname><given-names>A</given-names></name><name><surname>Pereira de Vasconcelos</surname><given-names>A</given-names></name></person-group><article-title>Glucose and ketone body utilization by the brain neonatal rat</article-title><source>Prog Neurobiol</source><year>1993</year><volume>40</volume><fpage>163</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/0301-0082(93)90022-K</pub-id><?supplied-pmid 8430212?><pub-id pub-id-type="pmid">8430212</pub-id></element-citation></ref><ref id="CR110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurse</surname><given-names>S</given-names></name><name><surname>Cobertt</surname><given-names>D</given-names></name></person-group><article-title>Neuroprotection after several days of mild, drug-induced hypothermia</article-title><source>J Cereb Blood Flow Metab</source><year>1996</year><volume>16</volume><fpage>474</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1097/00004647-199605000-00014</pub-id><?supplied-pmid 8621752?><pub-id pub-id-type="pmid">8621752</pub-id></element-citation></ref><ref id="CR111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odd</surname><given-names>DE</given-names></name><name><surname>Lewis</surname><given-names>G</given-names></name><name><surname>Whitelaw</surname><given-names>A</given-names></name><name><surname>Gunnell</surname><given-names>D</given-names></name></person-group><article-title>Resuscitation at birth and cognition at 8 years of age: a cohort study</article-title><source>Lancet</source><year>2009</year><volume>373</volume><fpage>1615</fpage><lpage>1622</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(09)60244-0</pub-id><?supplied-pmid 19386357?><pub-id pub-id-type="pmid">19386357</pub-id></element-citation></ref><ref id="CR112"><mixed-citation publication-type="other">Olah G, Szczesny B, Brunyanski A, Lopez-Garcia IA, Gero D, Radak Z, Szabo C (2015) Differentiation-associated down regulation of ply(ADP-ribose) polymerase-1 expression in myoblasts serves to increase their resistance to oxidative stress. PLoS One 10(7). 10.1371/journal.pne.0134227</mixed-citation></ref><ref id="CR113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orrenius</surname><given-names>S</given-names></name><name><surname>Nicotera</surname><given-names>P</given-names></name><name><surname>Zhivotovsky</surname><given-names>B</given-names></name></person-group><article-title>Cell death mechanisms and their implications in toxicology</article-title><source>Toxicol Sci</source><year>2011</year><volume>119</volume><fpage>3</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfq268</pub-id><?supplied-pmid 20829425?><pub-id pub-id-type="pmid">20829425</pub-id></element-citation></ref><ref id="CR114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>WL</given-names></name><name><surname>Liu</surname><given-names>KJ</given-names></name></person-group><article-title>Zinc promotes the death of hypoxic astrocytes by upregulating hypoxia-induced hypoxia-inducible factor-1alpha expression via poly(ADP-ribose) polymerase-1</article-title><source>CNS Neurosci Ther</source><year>2013</year><volume>19</volume><fpage>511</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1111/cns.12098</pub-id><?supplied-pmid 23582235?><pub-id pub-id-type="pmid">23582235</pub-id></element-citation></ref><ref id="CR115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papouin</surname><given-names>T</given-names></name><name><surname>Ladepeche</surname><given-names>L</given-names></name><name><surname>Ruel</surname><given-names>J</given-names></name><name><surname>Sacchi</surname><given-names>S</given-names></name><name><surname>Labasque</surname><given-names>M</given-names></name><name><surname>Hanini</surname><given-names>M</given-names></name><name><surname>Groc</surname><given-names>L</given-names></name><name><surname>Pollegioni</surname><given-names>L</given-names></name><name><surname>Mothet</surname><given-names>J-P</given-names></name><name><surname>Oliet</surname><given-names>SHR</given-names></name></person-group><article-title>Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists</article-title><source>Cell</source><year>2012</year><volume>150</volume><fpage>633</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.06.029</pub-id><?supplied-pmid 22863013?><pub-id pub-id-type="pmid">22863013</pub-id></element-citation></ref><ref id="CR116"><mixed-citation publication-type="other">Perez-Lobos R, Lespay-Rebolledo C, Tapia-Bustos A, Palacios E, Vio V, Bustamante D, Morales P, Herrera-Marschitz M (2017) Vulnerability to a metabolic challenge following perinatal asphyxia evaluated by organotypic cultures: neonatal nicotinamide treatment. Neurotox Res. doi: 10.1007/s12640-017-9755-4</mixed-citation></ref><ref id="CR117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Pinz&#x000f3;n</surname><given-names>MA</given-names></name><name><surname>Xu</surname><given-names>GP</given-names></name><name><surname>Born</surname><given-names>J</given-names></name><name><surname>Lorenzo</surname><given-names>J</given-names></name><name><surname>Busto</surname><given-names>R</given-names></name><name><surname>Rosenthal</surname><given-names>M</given-names></name><name><surname>Sick</surname><given-names>TJ</given-names></name></person-group><article-title>Cytochrome C is released from mitochondria into the cytosol after cerebral anoxia or ischemia</article-title><source>J Cereb Blood Flow Metab</source><year>1999</year><volume>19</volume><issue>1</issue><fpage>39</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1097/00004647-199901000-00004</pub-id><?supplied-pmid 9886353?><pub-id pub-id-type="pmid">9886353</pub-id></element-citation></ref><ref id="CR118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peruche</surname><given-names>B</given-names></name><name><surname>Krieglstein</surname><given-names>J</given-names></name></person-group><article-title>Mechanisms of drug actions against neuronal damage caused by ischemia&#x02014;an overview</article-title><source>Prog Neuro-Psychopharmacol Biol Psychiat</source><year>1993</year><volume>17</volume><fpage>21</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/0278-5846(93)90032-N</pub-id></element-citation></ref><ref id="CR119"><mixed-citation publication-type="other">Petralia RS (2012) Distribution of extrasynaptic NMDA receptors on neurons. Sci World J. doi: 10.1100/2012/267120</mixed-citation></ref><ref id="CR120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieper</surname><given-names>AA</given-names></name><name><surname>Walles</surname><given-names>T</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Clements</surname><given-names>EE</given-names></name><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name><name><surname>Zweier</surname><given-names>JL</given-names></name></person-group><article-title>Myocardial postischemic injury is reduced by poly-ADPribose polymerase-1 gene disruption</article-title><source>Mol Med</source><year>2000</year><volume>6</volume><fpage>272</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1007/s0089400060272</pub-id></element-citation></ref><ref id="CR121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirinen</surname><given-names>E</given-names></name><name><surname>Canto</surname><given-names>C</given-names></name><name><surname>Jo</surname><given-names>YS</given-names></name><name><surname>Morato</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Menzies</surname><given-names>KJ</given-names></name><name><surname>Williams</surname><given-names>EG</given-names></name><name><surname>Mouchiroud</surname><given-names>L</given-names></name><name><surname>Moullan</surname><given-names>N</given-names></name><name><surname>Hagberg</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Timmers</surname><given-names>S</given-names></name><name><surname>Imhof</surname><given-names>R</given-names></name><name><surname>Verbeek</surname><given-names>J</given-names></name><name><surname>Pujol</surname><given-names>A</given-names></name><name><surname>van Loon</surname><given-names>B</given-names></name><name><surname>Viscomi</surname><given-names>C</given-names></name><name><surname>Zeviani</surname><given-names>M</given-names></name><name><surname>Schrauwen</surname><given-names>P</given-names></name><name><surname>Sauve</surname><given-names>AA</given-names></name><name><surname>Schoonjans</surname><given-names>K</given-names></name><name><surname>Auwrrk</surname><given-names>J</given-names></name></person-group><article-title>Pharmacological inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle</article-title><source>Cell Metab</source><year>2014</year><volume>19</volume><fpage>1034</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.04.002</pub-id><?supplied-pmid 24814482?><pub-id pub-id-type="pmid">24814482</pub-id></element-citation></ref><ref id="CR122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piscopo</surname><given-names>P</given-names></name><name><surname>Bernardo</surname><given-names>A</given-names></name><name><surname>Calamandrei</surname><given-names>G</given-names></name><name><surname>Venerosi</surname><given-names>A</given-names></name><name><surname>Valanzano</surname><given-names>BD</given-names></name><name><surname>Confaloni</surname><given-names>A</given-names></name><name><surname>Minghetti</surname><given-names>L</given-names></name></person-group><article-title>Altered expression of cyclooxygenase-2, presenilins and oxygen radical scavenging enzymes in a rat model of global perinatal asphyxia</article-title><source>Exp Neurol</source><year>2008</year><volume>209</volume><fpage>192</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2007.09.014</pub-id><?supplied-pmid 17963755?><pub-id pub-id-type="pmid">17963755</pub-id></element-citation></ref><ref id="CR123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plenz</surname><given-names>D</given-names></name><name><surname>Kitai</surname><given-names>ST</given-names></name></person-group><article-title>Organotypic cortex-striatum-mesencephalon cultures: the nigrostriatal pathway</article-title><source>Neurosci Lett</source><year>1996</year><volume>209</volume><fpage>177</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(96)12644-6</pub-id><?supplied-pmid 8736639?><pub-id pub-id-type="pmid">8736639</pub-id></element-citation></ref><ref id="CR124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plenz</surname><given-names>D</given-names></name><name><surname>Kitai</surname><given-names>ST</given-names></name></person-group><article-title>Generation of high frequency oscillations in cortical circuits of somatosensory cortex cultures</article-title><source>J Neurophysiol</source><year>1996</year><volume>76</volume><fpage>4001</fpage><lpage>4005</lpage><pub-id pub-id-type="doi">10.1152/jn.1996.76.6.4180</pub-id></element-citation></ref><ref id="CR125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plenz</surname><given-names>D</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Kitai</surname><given-names>ST</given-names></name></person-group><article-title>Morphological organization of the subthalamic nucleus-globus pallidus system studied in organotypic cultures</article-title><source>J Comp Neurol</source><year>1998</year><volume>397</volume><fpage>437</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19980810)397:4&#x0003c;437::AID-CNE1&#x0003e;3.0.CO;2-2</pub-id><?supplied-pmid 9699909?><pub-id pub-id-type="pmid">9699909</pub-id></element-citation></ref><ref id="CR126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puka-Sundvall</surname><given-names>M</given-names></name><name><surname>Hallin</surname><given-names>U</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Karlsson</surname><given-names>JO</given-names></name><name><surname>Blomgren</surname><given-names>K</given-names></name><name><surname>Hagberg</surname><given-names>H</given-names></name></person-group><article-title>NMDA blockade attenuates caspase-3 activation and DNA fragmentation after neonatal hypoxia-ischemia</article-title><source>Neuroreport</source><year>2000</year><volume>11</volume><fpage>2833</fpage><lpage>2836</lpage><pub-id pub-id-type="doi">10.1097/00001756-200009110-00002</pub-id><?supplied-pmid 11006950?><pub-id pub-id-type="pmid">11006950</pub-id></element-citation></ref><ref id="CR127"><mixed-citation publication-type="other">Quincozes-Santos A, Bobermin LD, Tramontina AC, Wartchow KM, Taglisri B, Souza DA, Wyse ATS, Goncalves C-A (2014) Oxidtive stress mediated by NMDA, AMPA/KA channels in acute hippocampal slices: neuroprotective effect of resveratrol. Toxicol in Vitro 28: 544&#x02013;551.</mixed-citation></ref><ref id="CR128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintanilla</surname><given-names>ME</given-names></name><name><surname>Rivera-Meza</surname><given-names>M</given-names></name><name><surname>Berr&#x000ed;os-C&#x000e1;rcamo</surname><given-names>P</given-names></name><name><surname>Salinas-Luypaert</surname><given-names>C</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Israel</surname><given-names>Y</given-names></name></person-group><article-title>Beyond the &#x0201c;first hit&#x0201d;: marked inhibition by N-acetyl cysteine of chronic ethanol intake but not of early ethanol intake. Parallel effects on ethanol-induced saccharin motivation</article-title><source>Alcohol Clin Exp Res</source><year>2016</year><volume>40</volume><issue>5</issue><fpage>1044</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1111/acer.13031</pub-id><?supplied-pmid 27062046?><pub-id pub-id-type="pmid">27062046</pub-id></element-citation></ref><ref id="CR129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rammes</surname><given-names>G</given-names></name><name><surname>Danysz</surname><given-names>W</given-names></name><name><surname>Parsons</surname><given-names>CG</given-names></name></person-group><article-title>Pharmacodynamics of memantine: an update</article-title><source>Curr Neuropharmacol</source><year>2008</year><volume>6</volume><fpage>55</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.2174/157015908783769671</pub-id><?supplied-pmid 19305788?><pub-id pub-id-type="pmid">19305788</pub-id></element-citation></ref><ref id="CR130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>JE</given-names></name><name><surname>Vannucci</surname><given-names>RC</given-names></name><name><surname>Briley</surname><given-names>JB</given-names></name></person-group><article-title>The influence of immaturity on the hypoxic-ischemic brain damage in the rat</article-title><source>Ann Neurol</source><year>1981</year><volume>9</volume><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1002/ana.410090206</pub-id><?supplied-pmid 7235629?><pub-id pub-id-type="pmid">7235629</pub-id></element-citation></ref><ref id="CR131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MB</given-names></name><name><surname>Jackson</surname><given-names>JG</given-names></name></person-group><article-title>Astroglial glutamate transporter coordinate excitatory signaling and brain energetics</article-title><source>Neurochem Int</source><year>2016</year><volume>98</volume><fpage>56</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2016.03.014</pub-id><?supplied-pmid 27013346?><pub-id pub-id-type="pmid">27013346</pub-id></element-citation></ref><ref id="CR132"><mixed-citation publication-type="other">Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M (2006) The preterm parturition syndrome. BJOG (Suppl 3): 17-42.</mixed-citation></ref><ref id="CR133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name><name><surname>Fisher</surname><given-names>SJ</given-names></name></person-group><article-title>Preterm labor: one syndrome, many causes</article-title><source>Science</source><year>2014</year><volume>345</volume><fpage>760.765</fpage><pub-id pub-id-type="doi">10.1126/science.1251816</pub-id><pub-id pub-id-type="pmid">25124429</pub-id></element-citation></ref><ref id="CR134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostami</surname><given-names>E</given-names></name><name><surname>Rockesen</surname><given-names>D</given-names></name><name><surname>Ekberg</surname><given-names>NR</given-names></name><name><surname>Goiny</surname><given-names>M</given-names></name><name><surname>Ungerstedt</surname><given-names>U</given-names></name></person-group><article-title>Brain metabolism and oxygenation in healthy pigs receiving hypoventilation and hyperoxia</article-title><source>Respir Physiol Neurobiol</source><year>2013</year><volume>189</volume><fpage>537</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1016/j.resp.2013.08.010</pub-id><?supplied-pmid 24013004?><pub-id pub-id-type="pmid">24013004</pub-id></element-citation></ref><ref id="CR135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabir</surname><given-names>H</given-names></name><name><surname>Cowan</surname><given-names>FN</given-names></name></person-group><article-title>Prediction of outcome methods assessing short- and long-term outcomes after therapeutic hypothermia</article-title><source>Sem Fetal Neonatal Med</source><year>2015</year><volume>20</volume><fpage>115</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.siny.2014.10.006</pub-id></element-citation></ref><ref id="CR136"><mixed-citation publication-type="other">Sahin M, Sur M (2015) Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders. Science 350(6263). doi: 10.1126/science.aab3897</mixed-citation></ref><ref id="CR137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samarasinghe</surname><given-names>DA</given-names></name><name><surname>Tapner</surname><given-names>M</given-names></name><name><surname>Farrel</surname><given-names>GC</given-names></name></person-group><article-title>Role of oxidative stress in hypoxia-reoxygenation injury to cultured rt hepatic sinusoidal endothelial cells</article-title><source>Hepatology</source><year>2000</year><volume>31</volume><fpage>160</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1002/hep.510310124</pub-id><?supplied-pmid 10613741?><pub-id pub-id-type="pmid">10613741</pub-id></element-citation></ref><ref id="CR138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeman</surname><given-names>P</given-names></name><name><surname>Caruso</surname><given-names>C</given-names></name><name><surname>Lasaga</surname><given-names>M</given-names></name></person-group><article-title>Memantine agonist action at dopamine D2 high receptors</article-title><source>Synapse</source><year>2008</year><volume>62</volume><fpage>149</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1002/syn.20472</pub-id><?supplied-pmid 18000814?><pub-id pub-id-type="pmid">18000814</pub-id></element-citation></ref><ref id="CR139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shankaran</surname><given-names>S</given-names></name><name><surname>Pappas</surname><given-names>A</given-names></name><name><surname>McDonald</surname><given-names>SA</given-names></name></person-group><article-title>Childhood outcomes after hypothermia for neonatal encephalopathy</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><fpage>2085</fpage><lpage>2092</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1112066</pub-id><?supplied-pmid 22646631?><pub-id pub-id-type="pmid">22646631</pub-id></element-citation></ref><ref id="CR140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shankaran</surname><given-names>S</given-names></name><name><surname>Laptook</surname><given-names>AR</given-names></name><name><surname>Pappas</surname><given-names>A</given-names></name><name><surname>McDonald</surname><given-names>SA</given-names></name><name><surname>Tyson</surname><given-names>JE</given-names></name><name><surname>Poindexter</surname><given-names>BB</given-names></name><name><surname>Schibler</surname><given-names>K</given-names></name><name><surname>Bell</surname><given-names>EF</given-names></name><name><surname>Heyne</surname><given-names>RJ</given-names></name><name><surname>Pedroza</surname><given-names>C</given-names></name><name><surname>Bara</surname><given-names>R</given-names></name><name><surname>Van Meurs</surname><given-names>KP</given-names></name><name><surname>Grisby</surname><given-names>C</given-names></name><name><surname>Huitema</surname><given-names>CM</given-names></name><name><surname>Garg</surname><given-names>M</given-names></name><name><surname>Ehrenkranz</surname><given-names>RA</given-names></name><name><surname>Shepherd</surname><given-names>EG</given-names></name><name><surname>Chalak</surname><given-names>LF</given-names></name><name><surname>Hamrick</surname><given-names>SE</given-names></name><name><surname>Khan</surname><given-names>AM</given-names></name><name><surname>Reynolds</surname><given-names>AM</given-names></name><name><surname>Laughon</surname><given-names>MM</given-names></name><name><surname>Truog</surname><given-names>WE</given-names></name><name><surname>Sysart</surname><given-names>KC</given-names></name><name><surname>Carlo</surname><given-names>WA</given-names></name><name><surname>Walsh</surname><given-names>MC</given-names></name><name><surname>Watterberg</surname><given-names>KL</given-names></name><name><surname>Higging</surname><given-names>RD</given-names></name></person-group><article-title>Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial</article-title><source>JAMA</source><year>2014</year><volume>312</volume><fpage>2629</fpage><lpage>2639</lpage><pub-id pub-id-type="doi">10.1001/jama.2014.16058</pub-id><?supplied-pmid 25536254?><pub-id pub-id-type="pmid">25536254</pub-id></element-citation></ref><ref id="CR141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sies</surname><given-names>H</given-names></name></person-group><article-title>Hydrogen peroxide as a central redox signalling molecule in physiological oxidative stress: oxidative eustress</article-title><source>Redox Biol</source><year>2017</year><volume>11</volume><fpage>613</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2016.12.035</pub-id><?supplied-pmid 28110218?><pub-id pub-id-type="pmid">28110218</pub-id></element-citation></ref><ref id="CR142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simola</surname><given-names>N</given-names></name><name><surname>Bustmante</surname><given-names>D</given-names></name><name><surname>Pinna</surname><given-names>D</given-names></name><name><surname>Pontis</surname><given-names>S</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Morelli</surname><given-names>M</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name></person-group><article-title>Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats</article-title><source>Exp Brain Res</source><year>2008</year><volume>185</volume><fpage>597</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1007/s00221-007-1186-7</pub-id></element-citation></ref><ref id="CR143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sowter</surname><given-names>HM</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name><name><surname>Watson</surname><given-names>P</given-names></name><name><surname>Greenberg</surname><given-names>AH</given-names></name><name><surname>Harris</surname><given-names>AL</given-names></name></person-group><article-title>HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>6669</fpage><lpage>6673</lpage><?supplied-pmid 11559532?><pub-id pub-id-type="pmid">11559532</pub-id></element-citation></ref><ref id="CR144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanika</surname><given-names>RL</given-names></name><name><surname>Pivovarova</surname><given-names>NB</given-names></name><name><surname>Brantner</surname><given-names>CA</given-names></name><name><surname>Watts</surname><given-names>CA</given-names></name><name><surname>Winters</surname><given-names>CA</given-names></name><name><surname>Andrews</surname><given-names>SB</given-names></name></person-group><article-title>Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity</article-title><source>PNAS</source><year>2009</year><volume>106</volume><fpage>9854</fpage><lpage>9859</lpage><pub-id pub-id-type="doi">10.1073/pnas.0903546106</pub-id><?supplied-pmid 19482936?><pub-id pub-id-type="pmid">19482936</pub-id></element-citation></ref><ref id="CR145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starkov</surname><given-names>AA</given-names></name><name><surname>Chinopopulos</surname><given-names>C</given-names></name><name><surname>Fiskum</surname><given-names>G</given-names></name></person-group><article-title>Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury</article-title><source>Cell Calcium</source><year>2004</year><volume>36</volume><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2004.02.012</pub-id><?supplied-pmid 15261481?><pub-id pub-id-type="pmid">15261481</pub-id></element-citation></ref><ref id="CR146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tachikawa</surname><given-names>M</given-names></name><name><surname>Hosoya</surname><given-names>K</given-names></name><name><surname>Ohtsuki</surname><given-names>S</given-names></name><name><surname>Terasaki</surname><given-names>T</given-names></name></person-group><article-title>A novel relationship between creatine transport at the blood-brain and blood retinal barriers, creatine biosynthesis, and its use for brain and retinal homeostasis</article-title><source>Subcell Biochem</source><year>2007</year><volume>46</volume><fpage>83</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1007/978-1-4020-6486-9_5</pub-id><?supplied-pmid 18652073?><pub-id pub-id-type="pmid">18652073</pub-id></element-citation></ref><ref id="CR147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Xia</surname><given-names>CJ</given-names></name><name><surname>Talantova</surname><given-names>M</given-names></name><name><surname>Bodhinathan</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Holland</surname><given-names>EA</given-names></name><name><surname>Tong</surname><given-names>G</given-names></name><name><surname>Pina-Crespo</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Nakanishi</surname><given-names>N</given-names></name><name><surname>Larrick</surname><given-names>JW</given-names></name><name><surname>McKercher</surname><given-names>SR</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lipton</surname><given-names>SA</given-names></name></person-group><article-title>Pharmacologically targeted NMDA receptor antagonism by nitromemantine for cerebrovascular disease</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>14718</fpage><pub-id pub-id-type="doi">10.1038/srep14718</pub-id><pub-id pub-id-type="pmid">26434954</pub-id></element-citation></ref><ref id="CR148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tapia-Bustos</surname><given-names>A</given-names></name><name><surname>Lobos-Perez</surname><given-names>R</given-names></name><name><surname>Vio</surname><given-names>V</given-names></name><name><surname>Lespay-Rebolledo</surname><given-names>C</given-names></name><name><surname>Palacios</surname><given-names>E</given-names></name><name><surname>Chiti-Morales</surname><given-names>A</given-names></name><name><surname>Bustamante</surname><given-names>D</given-names></name><name><surname>Herrera-Marschitz</surname><given-names>M</given-names></name><name><surname>Morales</surname><given-names>P</given-names></name></person-group><article-title>Moduylation of postnatal neurogenesis by perinatal asphyxia: effect of D1 and D2 dopamine receptor agonists</article-title><source>Neurotox Res</source><year>2017</year><volume>31</volume><fpage>109</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1007/s12640-016-9669-6</pub-id><?supplied-pmid 27638511?><pub-id pub-id-type="pmid">27638511</pub-id></element-citation></ref><ref id="CR149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thoresen</surname><given-names>M</given-names></name><name><surname>Satas</surname><given-names>S</given-names></name><name><surname>Puka-Sundvall</surname><given-names>M</given-names></name><name><surname>Whitelaw</surname><given-names>A</given-names></name><name><surname>Hallstr&#x000f6;m</surname><given-names>A</given-names></name><name><surname>Loberg</surname><given-names>EM</given-names></name><name><surname>Ungerstedt</surname><given-names>U</given-names></name><name><surname>Steen</surname><given-names>PA</given-names></name><name><surname>Hagberg</surname><given-names>H</given-names></name></person-group><article-title>Post-hypoxic hypothermia reduces cerebrocortical release of NO and excitotoxins</article-title><source>Neuroreport</source><year>1997</year><volume>8</volume><fpage>3359</fpage><lpage>3362</lpage><pub-id pub-id-type="doi">10.1097/00001756-199710200-00033</pub-id><?supplied-pmid 9351672?><pub-id pub-id-type="pmid">9351672</pub-id></element-citation></ref><ref id="CR150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thoresen</surname><given-names>M</given-names></name><name><surname>Tooley</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Jary</surname><given-names>S</given-names></name><name><surname>Fleming</surname><given-names>P</given-names></name><name><surname>Luyt</surname><given-names>K</given-names></name><name><surname>Jain</surname><given-names>A</given-names></name><name><surname>Cairns</surname><given-names>P</given-names></name><name><surname>Harding</surname><given-names>D</given-names></name><name><surname>Sabir</surname><given-names>H</given-names></name></person-group><article-title>Time is brain: starting therapeutic hypothermia within three hours after birth improves motor outcome in asphyxiated newborns</article-title><source>Neonatology</source><year>2013</year><volume>104</volume><fpage>228</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1159/000353948</pub-id><?supplied-pmid 24030160?><pub-id pub-id-type="pmid">24030160</pub-id></element-citation></ref><ref id="CR151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toti</surname><given-names>P</given-names></name><name><surname>Felice</surname><given-names>DE</given-names></name><name><surname>Sch&#x000fc;rfeld</surname><given-names>K</given-names></name><name><surname>Stumpo</surname><given-names>M</given-names></name><name><surname>Bartolommei</surname><given-names>S</given-names></name><name><surname>Lombardi</surname><given-names>A</given-names></name><name><surname>Petraglia</surname><given-names>E</given-names></name><name><surname>Buonocore</surname><given-names>G</given-names></name></person-group><article-title>Cyclooxygenase-2 immunoreactivity in the ischemic neonatal human brain. An autopsy study</article-title><source>J Submicro Cytol Pathol</source><year>2001</year><volume>33</volume><fpage>245</fpage><lpage>249</lpage></element-citation></ref><ref id="CR152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trammell</surname><given-names>SA</given-names></name><name><surname>Schmidt</surname><given-names>MS</given-names></name><name><surname>Wedemann</surname><given-names>BJ</given-names></name><name><surname>Redpath</surname><given-names>P</given-names></name><name><surname>Jaksch</surname><given-names>F</given-names></name><name><surname>Dellinger</surname><given-names>RW</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Abel</surname><given-names>ED</given-names></name><name><surname>Migaud</surname><given-names>ME</given-names></name><name><surname>Brenner</surname><given-names>C</given-names></name></person-group><article-title>Nicotinamide riboside is uniquely and orally bioavailable in mice and humans</article-title><source>Nat Commun</source><year>2016</year><volume>17</volume><fpage>12948</fpage><pub-id pub-id-type="doi">10.1038/ncomms12948</pub-id></element-citation></ref><ref id="CR153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trotti</surname><given-names>D</given-names></name><name><surname>Lodi-Rizzini</surname><given-names>B</given-names></name><name><surname>Rossi</surname><given-names>D</given-names></name><name><surname>Haugeto</surname><given-names>O</given-names></name><name><surname>Racagni</surname><given-names>G</given-names></name><name><surname>Danbolt</surname><given-names>N</given-names></name><name><surname>Volterra</surname><given-names>A</given-names></name></person-group><article-title>Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism</article-title><source>EJN</source><year>1997</year><volume>9</volume><fpage>1236</fpage><lpage>1243</lpage><?supplied-pmid 9215707?><pub-id pub-id-type="pmid">9215707</pub-id></element-citation></ref><ref id="CR154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vangeison</surname><given-names>G</given-names></name><name><surname>Carr</surname><given-names>D</given-names></name><name><surname>Federoff</surname><given-names>HJ</given-names></name><name><surname>Rempe</surname><given-names>DA</given-names></name></person-group><article-title>The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes</article-title><source>J Neurosci</source><year>2008</year><volume>28</volume><fpage>1988</fpage><lpage>1993</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5323-07.2008</pub-id><?supplied-pmid 18287515?><pub-id pub-id-type="pmid">18287515</pub-id></element-citation></ref><ref id="CR155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanlandingham</surname><given-names>SC</given-names></name><name><surname>Kurz</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>HE</given-names></name></person-group><article-title>Thermodynamic aspects of therapeutic hypothermia</article-title><source>Resuscitation</source><year>2015</year><volume>86</volume><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.resuscitation.2014.09.028</pub-id><?supplied-pmid 25449351?><pub-id pub-id-type="pmid">25449351</pub-id></element-citation></ref><ref id="CR156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vannucci</surname><given-names>RC</given-names></name><name><surname>Vannucci</surname><given-names>SJ</given-names></name></person-group><article-title>A model of perinatal hypoxic-ischemic brain damage</article-title><source>Ann N Y Acad Sci</source><year>1997</year><volume>835</volume><fpage>234</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1997.tb48634.x</pub-id><?supplied-pmid 9616778?><pub-id pub-id-type="pmid">9616778</pub-id></element-citation></ref><ref id="CR157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vannucci</surname><given-names>RC</given-names></name><name><surname>Brucklacher</surname><given-names>RM</given-names></name><name><surname>Vannucci</surname><given-names>SJ</given-names></name></person-group><article-title>The effect of hyperglycemia on cerebral metabolism during hypoxia-ischemia in the immature rat</article-title><source>J Cer Blood Flow Metab</source><year>1996</year><volume>16</volume><fpage>1026</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1097/00004647-199609000-00028</pub-id></element-citation></ref><ref id="CR158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vannucci</surname><given-names>RC</given-names></name><name><surname>Brucklacher</surname><given-names>RM</given-names></name><name><surname>Vannucci</surname><given-names>SJ</given-names></name></person-group><article-title>Glycolysis in perinatal hypoxic-ischemic brain damage</article-title><source>Dev Neurosci</source><year>2005</year><volume>27</volume><fpage>185</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1159/000085991</pub-id><?supplied-pmid 16046853?><pub-id pub-id-type="pmid">16046853</pub-id></element-citation></ref><ref id="CR159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vizi</surname><given-names>ES</given-names></name><name><surname>Kisfali</surname><given-names>M</given-names></name><name><surname>Lorincz</surname><given-names>T</given-names></name></person-group><article-title>Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selective inhibits these receptors and may have neuroprotective effects</article-title><source>Brain Res Bull</source><year>2013</year><volume>93</volume><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.brainresbull.2012.10.005</pub-id><?supplied-pmid 23089362?><pub-id pub-id-type="pmid">23089362</pub-id></element-citation></ref><ref id="CR160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volbracht</surname><given-names>C</given-names></name><name><surname>van Beek</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Blomgren</surname><given-names>K</given-names></name><name><surname>Leist</surname><given-names>M</given-names></name></person-group><article-title>Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity</article-title><source>Eur J Neurosci</source><year>2006</year><volume>23</volume><fpage>2611</fpage><lpage>2622</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04787.x</pub-id><?supplied-pmid 16817864?><pub-id pub-id-type="pmid">16817864</pub-id></element-citation></ref><ref id="CR161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>GL</given-names></name><name><surname>Jiang</surname><given-names>BH</given-names></name><name><surname>Rue</surname><given-names>EA</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name></person-group><article-title>Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension</article-title><source>Proc Natl Acad Sci U S A</source><year>1995</year><volume>92</volume><fpage>5510</fpage><lpage>5514</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.12.5510</pub-id><?supplied-pmid 7539918?><pub-id pub-id-type="pmid">7539918</pub-id></element-citation></ref><ref id="CR162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SP</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>JW</given-names></name><name><surname>Gauthier</surname><given-names>N</given-names></name><name><surname>Fukao</surname><given-names>T</given-names></name><name><surname>Mitchell</surname><given-names>GA</given-names></name></person-group><article-title>Metabolism as a tool for understanding human brain evolution: lipid energy metabolism as an example</article-title><source>J Hum Evol</source><year>2014</year><volume>77</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.jhevol.2014.06.013</pub-id><?supplied-pmid 25488255?><pub-id pub-id-type="pmid">25488255</pub-id></element-citation></ref><ref id="CR163"><mixed-citation publication-type="other">Wang SN, Xu TY, Li WL, Miao CY (2016) Targetting nicotinamide phosphoribosyltransferase as a potential therapeutic strategy to restore adult neurogenesis. CNS Neurosci Ther 22: 431&#x02013;439</mixed-citation></ref><ref id="CR164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>TY</given-names></name><name><surname>Li</surname><given-names>WL</given-names></name><name><surname>Miao</surname><given-names>CY</given-names></name></person-group><article-title>Targeting nicotinamide phosphoribosyltransferase as a potential therapeutic strategy to restore adult neurogenesis</article-title><source>Science</source><year>2016</year><volume>353</volume><fpage>82</fpage></element-citation></ref><ref id="CR165"><mixed-citation publication-type="other">Wassink G, Gunn ER, Drury PR, Bennet L, Gunn AJ (2014) The mechanisms and treatment of asphyxia encephalopathy. Frontiers Neurosci 8:40. doi: 10.3389/fnins.2014.00040.eCollection2014</mixed-citation></ref><ref id="CR166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watabe</surname><given-names>S</given-names></name><name><surname>Hiroi</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Fujioka</surname><given-names>Y</given-names></name><name><surname>Hasegawa</surname><given-names>H</given-names></name><name><surname>Yago</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name></person-group><article-title>SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria</article-title><source>Eur J Biochem</source><year>1997</year><volume>249</volume><fpage>52</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.1997.t01-1-00052.x</pub-id><?supplied-pmid 9363753?><pub-id pub-id-type="pmid">9363753</pub-id></element-citation></ref><ref id="CR167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wink</surname><given-names>LK</given-names></name><name><surname>Adams</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Klauning</surname><given-names>JE</given-names></name><name><surname>Plawecki</surname><given-names>MH</given-names></name><name><surname>Posey</surname><given-names>DJ</given-names></name><name><surname>McDougle</surname><given-names>CJ</given-names></name><name><surname>Erickson</surname><given-names>CA</given-names></name></person-group><article-title>A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder</article-title><source>Mol Autism</source><year>2016</year><volume>7</volume><fpage>26</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1186/s13229-016-0088-6</pub-id><?supplied-pmid 27103982?><pub-id pub-id-type="pmid">27103982</pub-id></element-citation></ref><ref id="CR168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>HS</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Lipton</surname><given-names>SA</given-names></name></person-group><article-title>Memantine preferentially blocks extrasynaptic over synaptic NMDA receptors</article-title><source>J Neurosci</source><year>2010</year><volume>30</volume><fpage>11246</fpage><lpage>11250</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2488-10.2010</pub-id><?supplied-pmid 20720132?><pub-id pub-id-type="pmid">20720132</pub-id></element-citation></ref><ref id="CR169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Voloboueva</surname><given-names>LA</given-names></name><name><surname>Ouyang</surname><given-names>Y</given-names></name><name><surname>Emery</surname><given-names>J</given-names></name><name><surname>Giffard</surname><given-names>R</given-names></name></person-group><article-title>Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia</article-title><source>J Cereb Blood Flow Metab</source><year>2009</year><volume>29</volume><fpage>365</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1038/jcbfm.2008.125</pub-id><?supplied-pmid 18985056?><pub-id pub-id-type="pmid">18985056</pub-id></element-citation></ref><ref id="CR170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Ryu</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Gariani</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Luan</surname><given-names>P</given-names></name><name><surname>D&#x02019;Amico</surname><given-names>D</given-names></name><name><surname>Ropelle</surname><given-names>ER</given-names></name><name><surname>Lutolf</surname><given-names>MP</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><name><surname>Schoonlas</surname><given-names>K</given-names></name><name><surname>Menzies</surname><given-names>KJ</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name></person-group><article-title>NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice</article-title><source>Science</source><year>2016</year><volume>352</volume><fpage>1436</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1126/science.aaf2693</pub-id><?supplied-pmid 27127236?><pub-id pub-id-type="pmid">27127236</pub-id></element-citation></ref></ref-list></back></article>